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 Studying novel proteins and their behavior in disease states often leads to 
elucidation of their function in vivo and provides a platform to guide drug development 
and treatment efforts. Recent patient studies have shown that a fatal mitochondrial disease, 
multiple mitochondrial dysfunctions syndrome 1 (MMDS1) arises from two distinct 
genetic mutations near the active site of the essential iron-sulfur (Fe/S) protein NFU1. 
Symptoms of MMDS1 include impairment of neurological development, lactic acidosis, 
failure to thrive, and ultimately death in infancy – all indicative of a general failure of the 
metabolic system.  Reduced function of target Fe/S proteins lipoic acid synthetase (LIAS) 
and succinate dehydrogenase (SDH) in the MMDS1 disease state suggests that multiple 
metabolic pathways require proper function of the native NFU1 protein through Fe/S 
cluster delivery and trafficking. However, the precise function of NFU1 remains unknown, 
and there is no treatment or cure for MMDS1. To investigate the molecular consequences 
of the disease-causing Gly208Cys and Gly189Arg mutations, the structure and function of 
the mutant human NFU1 protein forms were analyzed in vitro using a suite of biochemical 
techniques and compared to data obtained for the native construct. In the case of G208C 
NFU1, the mutation initiates a global structural change, which alters the monomer-dimer 
equilibrium such that it is unable to receive an Fe/S cluster from physiologically-relevant 
sources. Preliminary data suggests a similar phenomenon could be occurring in the case of 




mutations at positions 189 and 208, along with cluster-binding residues at positions 210 
and 213 have provided an in-depth investigation into the effects of mutation on Fe/S cluster 
coordination and transfer, and corroborated conclusions drawn from study of the G208C 
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Chapter 1 : Introduction 
 
Although categorized as inorganic ions, life would not be possible without the 
diverse range of alkali, alkaline and transition metals, along with other main group atoms 
that give rise to the field of bioinorganic chemistry. It is estimated that twenty-one 
elements, including fourteen metals, are essential for human life [1], and that forty percent 
of enzymes rely on a metal ion for catalysis [2] (Fig. 1.1). The alkali and alkaline ions Na+, 
K+, Mg2+, and Ca2+ are the most abundant metal ions in biological systems, and have 
diverse roles in regulation of energy metabolism and cellular signaling, catalysis, structural 
stabilization of several classes of macromolecules, and composition of skeletal mass [3]. 
Transition metals (e.g. Fe2+, Co2+, and Ni2+) possess generally less defined, yet richly 
diverse roles, as nature has employed these metals to perform a wide variety of redox and 
non-redox reactions. On account of the diverse coordination chemistry of transition metals 
demonstrated in their varied geometry, redox states, and kinetic and thermodynamic 
stabilities, metalloproteins with these cofactors are able to catalyze non-redox reactions, 
store and transfer cellular substrates such as oxygen, and regulate activity of other 
biological macromolecules [3]. 
Unsurprisingly, due to the complexity of the metallome and the large number of 
macromolecules dependent on metal ions for proper structure and function, misregulation 
of cellular metal ion concentrations often results in disease. Efficient metal uptake is 




intracellular availability of metal ions, but because the extracellular availability of certain 
metal ions, such as iron, copper and zinc, can promote bacterial growth and virulence, and 
enhance microbial infection [4,5]. For example, iron availability is relevant in certain 
chronic disease states, such as acquired immunodeficiency disease (AIDS), in which iron 
is rapidly sequestered by macrophages in order to defend against infection; although the 
overall iron levels of the patient remain unchanged, the Fe is no longer available to tissues, 
causing anemia of chronic disease [5]. In addition to pathogenic disease states, 
accumulation of metal ions contributes to the onset and severity of various 
neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases by inducing 
oxidative stress and protein misfolding, disrupting mitochondrial function, and impairing 
the activity of metalloenzymes [6,7].  
Because metal ions are necessary for life, though toxic in excess, highly-conserved 
and complex systems have evolved in order to acquire, transport, sequester, and incorporate 
these ions into cellular machinery. Of particular interest is iron (Fe), an essential nutrient 
utilized in a variety of biochemical and physiological processes, most notably for oxygen 
transport via hemoglobin, cellular respiration, and DNA synthesis [7,8]. Dietary Fe is 
imported from the intestines via DMT1 (divalent metal transporter 1), where it is reduced 
via reductase activity, exported by the basolateral iron exporter FPN, and incorporated into 
transferrin (Tf) for transport throughout the body [9]. Cells then obtain Fe through receptor-
mediated endocytosis of Fe-bound Tf via transferrin receptors (TFR1 and TFR2) 
facilitating the release of the Fe, which is then incorporated into the labile Fe pool, stored 




concentration is achieved most importantly at the translational level via the IRE/IRP 
regulatory system, which is organized via the binding of multifunctional iron-regulatory 
proteins to regulatory mRNA motifs known as MREs [11]. 
Although several enzymes such as ribonucleotide reductase (RNR) utilize Fe 
centers to accomplish their chemistry, Fe ions are often incorporated with sulfide (S2-) ions 
to form cofactors known as iron-sulfur (Fe-S) clusters. Fe-S clusters are highly-conserved 
inorganic prosthetic groups present across all kingdoms of life from bacteria to humans. 
Proteins that utilize an Fe-S cluster, known as Fe-S proteins, comprise the largest class of 
metalloproteins and are located ubiquitously throughout the mitochondria, cytosol and 
nucleus [12,13]. Consequently, Fe-S proteins play diverse roles in the cell. Fe-S clusters 
are central to the electron transfer reactions of respiratory chain complexes I-III and in 
photosystem I of photosynthetic organisms, while other Fe-S cluster proteins are involved 
in regulation of gene expression, such as aconitase or IRP1, which are activated in the 
absence of a [4Fe-4S] cluster cofactor [14].  Additionally, Fe-S proteins can serve as O2 
sensors, such as the bacterial FNR (fumarate and nitrate reduction) regulatory proteins, due 
to the sensitivity of Fe-S clusters to oxidation. Cellular roles of Fe-S clusters have expanded 
even further, since proteins involved in DNA replication and repair, including eukaryotic 
DNA polymerases and DNA helicases, have recently been shown to be Fe-S proteins 
[14,15]. Despite the ubiquity of Fe-S proteins, and the essential processes they catalyze, 
the exact function or functions of the Fe-S cluster in many of these processes, and how the 




Fe-S clusters can adopt several geometries, the most abundant being the rhomboid 
[2Fe-2S] and the cubane [4Fe-4S] clusters (Fig. 1.2) [16], and these clusters are typically 
coordinated via cysteine residues [17], although non-cysteinyl ligands such as histidine 
[18], arginine [19], serine [20], or water [21] have been observed  [14,15]. The chemical 
reactivity of iron and sulfur, along with the variation in geometry, oxidation state, and local 
protein environment enables Fe-S proteins to participate in the diverse functions described 
above and a wide variety of additional biological processes [22]. However, because of their 
oxygen sensitivity, formation and insertion of Fe-S clusters requires complex machineries, 
which are conserved across eukaryotic and some prokaryotic organisms, with the most 
common one being the ISC (iron-sulfur cluster) system (Fig 1.3), and defects in this system 
have been linked to a wide variety of human diseases [14,15,23]. 
In humans, iron-sulfur cluster biosynthesis occurs in the mitochondria via the ISC 
assembly pathway [24]. The first step in this pathway for reconstitution of downstream Fe-
S proteins is the de novo formation of a transient [2Fe-2S] cluster on the scaffold protein 
IscU [15]. Central to this process is the cysteine desulfurase complex NFS1-ISD11, which 
catalyzes the conversion of cysteine to alanine for sulfur delivery to IscU, likely via a 
persulfide intermediate on IscU [15]. The sulfur is then reduced from elemental (S0) to 
sulfide (S2-) in a process involving NAD(P)H, ferredoxin reductase (FDXR), and 
ferredoxin 2 (Fdx2) [15]. Fe is transported into the mitochondria using the proton motive 
force via the mitoferrin 1/2 importers. Once imported, frataxin (FXN) or a glutaredoxin-




Once the [2Fe-2S] cluster is built on IscU, a chaperone system facilitates the release 
of the cluster from the scaffold to a cluster delivery protein glutaredoxin 5 (Glrx5) [15]. 
Mammals and many other eukaryotes rely on the multi-functional heat shock protein 70 
(HspA9) and co-chaperone Hsc20 [14]. Glrx5 binds to this complex of the chaperone, co-
chaperone, and cluster-bound IscU, so that ATP hydrolysis at HSPA9 can drive transfer of 
cluster from IscU to monothiol Glrx5 for downstream cluster trafficking [15,25].  Current 
models suggest that Glrx5 is the sole cluster transport intermediary between Fe/S scaffold 
machinery and downstream targets; however, a variety of other Fe/S proteins can 
complement this function with relatively rapid rate constants in comparison to Glrx5 [26-
28].  
From Glrx5, the [2Fe-2S] cluster can be incorporated into [2Fe-2S] proteins, 
exported into the cytosol to the cytosolic Fe-S cluster assembly (CIA) system via the 
ABCB7 transporter, or matured into a [4Fe-4S] cluster [15,25]. Cluster export from the 
mitochondria through ABCB7 is thought occur via a glutathione-coordinated [2Fe-2S] 
cluster complex, [Fe2S2](GS)4, which can also function as part of the labile iron pool for 
Fe/S cluster delivery and trafficking [26,29-31]. The process of [4Fe-4S] cluster maturation 
involves proteins IscA1/2 and Iba57, which are thought to form a complex that binds free 
iron and a [2Fe-2S] cluster; yet it remains unknown how the IscA proteins use the iron and 
[2Fe-2S] cluster in the formation of the [4Fe-4S] cluster [14,15] . After the proposed 
formation of a [4Fe-4S] cluster on IscA1/2, a number of additional Fe-S cluster delivery 
proteins have been implicated in maturation of clusters at their final targets due to the 




NFU1 was first thought to serve as a cluster scaffold acting in parallel to IscU, until patient 
studies revealed that a defect in NFU1 expression or function resulted in improper cluster 
assembly of certain [4Fe-4S] proteins including respiratory complexes I and II, and lipoic 
acid sythetase (LIAS) [15]. Likewise, BOLA3 was identified as another late-acting ISC 
assembly factor when it was shown that a frameshift mutation in the gene resulted in a 
biochemical phenotype similar to that observed in NFU1-deficient individuals, though the 
molecular function of BOLA3 remains unknown [15]. A third ISC targeting factor IND1, 
a P-loop NTPase, specifically targets only respiratory chain complex I, with other [4Fe-
4S] proteins such as LIAS being unaffected [15]. However, the current model of various 
Fe/S biosynthesis proteins is primarily based on disease phenotypes and yeast knockouts, 
so further biochemical refinement is necessary for a mechanistic understanding of the 
molecular basis for disease. 
Given the inherent structural and functional complexity of the mitochondria, 
combined with the necessary biosynthetic processes such as ISC assembly that occur 
therein, mitochondrial defects can cause a wide variety of severe and generally untreatable 
disorders. Figure 1.3 highlights the proteins involved in ISC assembly that have also been 
implicated in human diseases, such as Glrx5 and ACBC7 in sideroblastic anemia and Fxn 
in Friedreich’s ataxia (Fig. 1.3) [15]. Multiple mitochondrial dysfunctions syndrome 
(MMDS) is a class of untreatable and fatal diseases that describes the severe impairment 
of various metabolic pathways and energy production as a consequence of single 
nucleotide genetic mutations in NFU1, BOLA3, IscA2, and IBA57 [15,32-38]. Further 




these late-acting ISC assembly and trafficking proteins will contribute to a better 
understanding of how the pathway operates, how cluster is transported in vivo, and why 
mutation causes an abrupt and severe interruption in this pathway with the potential to 
direct research towards finding a disease treatment.  Herein, I describe investigation into 
two disease-causing substitutions in NFU1, as well as an examination into the effects of 
several Fe-S cluster binding-site mutations on Fe-S cluster coordination and NFU1 




Figure 1-1 A partial representation of the periodic table of the elements indicating elements 
essential for life.  
Elements essential for most forms of life are colored in black, with the exception of 
chromium (colored in a diagonal pattern) whose role in biology is still under debate. 






Figure 1-2 Structure of canonical [2Fe-2S], [3Fe-4S], and [4Fe-4S] clusters 
 shown with cysteine ligation, although alternative ligands such as serine, histidine and 
arginine have been observed. Adapted from [16].  
 
 
Figure 1-3 Current proposed schematic of mitochondrial ISC assembly  
adapted from [15]. The various stages of cluster development are highlighted from import 
of ferrous ions and desulfurase activity to build a [2Fe-2S] cluster on the IscU scaffold. 
From IscU, the [2Fe-2S] cluster is transferred to Glrx5 via the HspA9/Hsc20 chaperone 
system. At this point in the ISC assembly pathway, the [2Fe-2S] cluster is exported to CIA 
machinery via ABCB7 as [Fe2S2](GS)4, incorporated into various [2Fe-2S] proteins, or 
matured into a [4Fe-4S] cluster where it is incorporated into various [4Fe-4S] proteins by 




whose genes are mutated in human Fe/S diseases. This model is primarily based on disease 
phenotypes and yeast knockouts, so further biochemical refinement is necessary for a 







Chapter 2 : Understanding the Molecular Basis for Multiple Mitochondrial Dysfunctions 
Syndrome 1 (MMDS1) - Impact of a Disease-Causing Gly208Cys Substitution on 
Structure and Activity of NFU1 in the Fe/S Cluster Biosynthetic Pathway 
 
2.1 Introduction 
Mitochondria are complex eukaryotic organelles that serve as the site of aerobic cellular 
metabolism and energy production via oxidative phosphorylation. Furthermore, many 
important and diverse pathways for the production of essential biological cofactors are 
localized to the mitochondria [40-42]. Given the inherent structural and functional 
complexity of the mitochondria, combined with the necessary biosynthetic processes that 
occur there, mitochondrial defects can cause a wide variety of severe and generally 
untreatable disorders [40,43]. Multiple mitochondrial dysfunctions syndrome (MMDS) 
constitutes a class of typically fatal diseases that result from the severe impairment of 
various metabolic pathways and energy production as a consequence of single nucleotide 
genetic mutations [32,44]. Symptoms of MMDS include hypotonia, respiratory 
insufficiency, hyperglycinemia, encephalopathy, neurological regression, and failure to 
thrive, indicative of decreased functional actions of mitochondrial respiratory complexes 
[45-47]. Additional symptoms of MMDS are related to a deficiency of mitochondrial 
respiratory complexes and impaired function of lipoic acid dependent enzymes, such as 
pyruvate dehydrogenase (PDH) and protein H of the Glycine Cleavage System (GCS) 
[38,43,44].  Due to the severity and extent of symptoms described above, MMDS is 
typically fatal during perinatal stages [44]; however, some patients have lived until the age 




Interestingly, all four types of MMDS so far identified are associated with genes that code 
for metalloproteins, specifically those involved in the biosynthesis of iron-sulfur clusters: 
IBA57, IscA2, BOLA3, or NFU1 [32-37,44]. Further inspection of the defects caused by 
these iron-sulfur cluster proteins has revealed a specific impairment of downstream [4Fe-
4S]-cluster-containing proteins; by contrast, [2Fe-2S]-cluster-containing proteins and 
cytosolic iron-sulfur cluster proteins appear unaffected [32,33,43]. All four of the identified 
proteins have been implicated in iron-sulfur cluster biosynthetic pathways as mediators of 
cluster transfer and delivery. Iron-sulfur clusters are highly conserved inorganic prosthetic 
groups that are present across all kingdoms of life and play diverse roles in the cell, 
including electron transfer, regulation of gene expression, and disulfide reduction [12,48].   
Herein, we have focused on one of the aforementioned Fe/S proteins, NFU1. Human NFU1 
consists of two domains, an N- and a C-terminal domain [49-52], where the latter contains 
a highly conserved CXXC motif [52] that identifies this domain as the Nfu domain and 
suggests a role in iron-sulfur cluster binding, assembly, and transport, based on comparison 
to homologous proteins and the high level of sequence conservation [53-57]. The 
thermodynamic stability of NFU1 has been studied in depth to reveal that the isolated C-
terminal domain of human NFU1 exhibits characteristics of a molten globular state [49,51], 
while the isolated N-terminal domain demonstrates a highly ordered structure. However, 
when the two domains come together the overall protein maintains a relatively well-folded 
structure, suggesting a requirement for the unique N-terminal domain of the human protein 
to provide structural stabilization as well as serving a potential functional role [49,51] that 




Hsc20 [22,58]. Structure-function characteristics of human NFU1 remain unclear, because 
this protein has been implicated in a variety of cellular roles. NFU1 is also known as the 
HIRA-interacting protein, where HIRA is the histone cell cycle regulation homologue A 
[59]. Furthermore, it exhibits thioredoxin-like activity in the apo form [50,51], assembles 
and transfers a [2Fe-2S] cluster [28], assembles a [4Fe-4S] cluster [52,60], and may 
transfer cluster to apo aconitase [58].  Homologs of human NFU1 have been implicated in 
similar roles, with [2Fe-2S] [54,55,57,61] and [4Fe-4S] [53,54,56,62] cluster transfer, 
suggesting that both functionalities are possible and potentially physiologically relevant. 
Most recently, NFU1 has been implicated in the disease phenotype of MMDS1 attributed 
to a c.622G>T missense mutation located in the gene encoding the protein NFU1 [32,38]. 
This introduces a p.Gly208Cys missense mutation in the protein close to the iron-sulfur 
(Fe/S) cluster binding motif (Fig. 1) that alters the region around the cluster binding motif 
from GXCXXC to CXCXXC.  
In connection with the MMDS1 disease state, human NFU1 has been proposed to be 
involved in the maturation of the iron-sulfur clusters on the [4Fe-4S] target proteins lipoate 
synthase (LIAS) and succinate dehydrogenase (SDH) [32,38,60]. In patients with MMDS1, 
laboratory tests have demonstrated that the level of human NFU1 protein is not diminished 
[32,38,63], but the activity levels of LIAS and SDH are significantly impaired, while other 
[4Fe-4S] targets, such as aconitase, are relatively unaffected [32,38,63]. Despite the 
identification of the global cellular effect of the NFU1 mutation, there remains a lack of 




have undertaken a biochemical approach to determine the impact of this mutation on the 
structure-function relationship of human NFU1.  
 
2.2 Materials and Methods 
2.2.1 Materials 
PD10 desalting columns were purchased from GE Healthcare. Ferric chloride, sodium 
sulfide, DTT (Dithiothreitol), TCEP (Tris (2-carboxy-ethyl) phosphine) and L-cysteine 
were purchased from Fisher. 
 
2.2.2 Mutagenesis 
Stratagene QuikChange Mutagenesis was employed to introduce the p.Gly208Cys point 
mutation in full length human NFU1. PCR reactions contained 50 ng of native NFU1 DNA 
in the pET28b+plasmid, 2 units of Phusion DNA polymerase (New England Biolabs), 10x 
Phusion buffer (New England Biolabs), 125 ng of each primer (Integrated DNA 
Technologies), 0.2 mM dNTPs, and 3% DMSO.  The forward primer sequence was 5’-
TACAGCTGAAACTCCAGTGTTCTTGTACCAGCTGC-3’ and the reverse primer 
sequence was 5’-GCAGCTGGTACAAGAACACTGGAGTTTCAGCTGTA-3’ with the 
substituted nucleotide in bold.  The thermocycle was identical to that described in the 
QuikChange manual: the sample was melted by heating to 95 ˚C for 1 min, followed by 16 
cycles of 95 ˚C for 30 sec, 55 ˚C for 1 min and 72 ˚C for 6.5 min (Stratagene).  Following 
amplification, samples were incubated with 7.5 units of DpnI at 37 ˚C for 4 hours.  




the mutant constructs.  Mutagenesis results were confirmed by nucleotide sequencing from 
GENEWIZ.   
 
2.2.3 Protein Expression and Purification 
Full length human G208C NFU1 in a pET28(b+) vector in E. coli strain BL21(DE3) host 
cells was grown overnight at 37 °C in 10 mL of Luria–Bertani (LB) broth media containing 
kanamycin (50 μM) [50]. The overnight cultures were diluted 1:1000 in LB media 
containing 50 μM kanamycin until the OD600 reached 0.6. At this point, protein expression 
was induced with 0.5 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG), and cultures 
were incubated overnight at 37 °C. Cell pellets were collected by centrifugation at 4,330g 
for 15 min at 4 °C, and resuspended in 30 mL of 50 mM HEPES, 100 mM NaCl, and pH 
7.5. Resuspended pellets were incubated with 30 mg lysozyme and 0.6 mg DNase I for 30 
min at 4 °C, and then lysed by use of a dismembranator. Cell lysate was centrifuged at 
28,982g for 50 min at 4 °C, and the supernatant was applied to a TALON column. Protein 
was eluted with a buffer containing 50 mM HEPES, 100 mM NaCl, 150 mM imidazole, 
pH 7.5 and concentrated by Amicon ultrafiltration over a 10 kDa membrane. 
Purification of Hs IscU and Thermatoga maritima (Tm) Nifs was performed as previously 
reported [64-66]. The expression vector for human ferredoxin-1 (Hs Fdx1) was kindly 
provided by J. Markley and protein was expressed and purified according to literature 
procedures [67]. Purification for human ferredoxin-2 (Hs Fdx2) was performed as 
previously reported [68]. Briefly, Hs Fdx1 was purified by use of DE-52 anion exchange 




column (HR 16/50, Pharmacia) run at 0.2 mL/min with 50 mM HEPES, 100 mM NaCl, 
pH 7.5 at 40 C. All colored fractions were collected and combined.  Purification for human 
ferredoxin-2 (Hs Fdx2) was performed as previously reported [68], by use of a TALON 
column. Protein was eluted with a buffer containing 50 mM HEPES, 100 mM NaCl, 150 
mM imidazole, pH 7.5 and concentrated by amicon ultrafiltration over a 10 kDa membrane. 
The ferredoxins purified as holo proteins and were then subsequently converted to apo 
forms by treatment with 100 mM EDTA, 5mM DTT and 8M urea in a buffered solution, 
pH 7.5. A construct of human Grx2 (comprising residues 56-161), with a tobacco etch virus 
cleavable N-terminal His6 tag in expression vector pNic-Bsa4, was kindly provided by Drs. 
Kavanagh, Muller-Knapp and Oppermann and protein was expressed and purified as 
previously reported [69]. Schizosaccharomyces pombe Isa1 protein was expressed and 
purified as previously reported [70]. Yeast Grx3 (Δ1–35) in pET28b(+) E. coli BL21 (DE3) 
was purified as noted [26]. Human HSPA9 with a N-terminal 6X-His tag was purified as 
previously described [71], as was human Hsc20 [72]. 
In all cases, protein purity was assayed by use of a 12 % SDS-PAGE gel that was 
visualized with Coomassie Blue staining. Imidazole was removed by dialysis at 4 °C 
against a buffer containing 50 mM HEPES, 100 mM NaCl, pH 7.5, and protein 
concentration was determined by use of the Bradford assay and confirmed by ε280.  
 
2.2.4 Differential Scanning Calorimetry (DSC) 
DSC samples (0.1 mM – 0.3 mM) were dialyzed against 50 mM HEPES, 100 mM NaCl, 




Laboratories, Inc.).  The resulting dialysis buffers were used as reference cell buffers for 
precision and repeatability.  Reference buffers and protein samples were thoroughly 
degassed using a MicroCal Thermovac2 (Malvern Instruments, Inc.) prior to analysis on a 
MicroCal VP-DSC (Malvern Instruments, Inc.).  The data were obtained using a 
differential mode at a rate of 1.0 ˚C per minute from 10 ˚C to 100 ˚C and analyzed using 
Origin software (Origin Labs) and fit to a non-two state model [49].  
 
2.2.5 Variable Temperature Circular Dichroism characterization 
Circular dichroism (CD) samples (10 μM) were dialyzed in phosphate buffer (40 mM 
phosphate, pH 7.4) with Spectra/Por dialysis membrane (MWCO 10 000; Spectrum 
Laboratories, Inc.). The resulting dialysis buffers were used as reference cell solvents for 
precision and repeatability. Prior to analyses, all sample and reference solutions were 
rigorously degassed with a Microcal Thermovac2 device (Malvern Instruments, Inc.). All 
CD data acquisitions were obtained on a JASCO J-815 CD spectrometer (JASCO) 
equipped with quartz cells with a 0.1 cm path length. Variable temperature studies were 
performed at a rate of 0.4 ° C min-1 from 20 to 95 °C. All data were processed with Origin 
7 (Origin Laboratories). VTCD data were fit to equation 1 [49], where R is the ideal gas 
constant in calories per mole, Tm is the melting temperature in Kelvin, ΔHV is the van’t 
Hoff enthalpy, and Cp is the heat capacity. F and U represent the mean residue ellipticities 
(θmr) of the folded and unfolded protein, respectively.   
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2.2.6 Secondary Structure Prediction from Circular Dichroism 
Protein samples at 10 µM in 40 mM phosphate, pH 7.4 were placed in a 1 mm quartz 
cuvette and the signal monitored from 300 – 165 nm. The buffer baseline signal was 
subtracted from the data sets before conversion to ∆ε. The resulting CD spectra were 
processed using the analysis program CDSSTR [73] using reference set 7 [74] found on 
the online server Dichroweb [75,76].  
 
2.2.7 Reconstitution of apo proteins 
NifS-mediated in vitro reconstitution of G208C NFU1 was completed as previously 
described [28,77] . Briefly, ferric chloride and L-cysteine were added to an anaerobic 
mixture of approximately 200 μM purified NFU1, 2 μM T. maritima (Tm) NifS, and 5 mM 
DTT to final concentrations of 1.6 mM FeCl3 and 3.2 mM L-cysteine. Alternatively, 
sodium sulfide and ferric chloride were added to an anaerobic mixture of approximately 
200 μM purified NFU1, 2.1 mM urea, and 5 mM DTT to final concentrations of 1 mM 
FeCl3 and 1 mM Na2S [26]. The final solution was incubated for 1 h with stirring at room 




equilibrated with an argon-purged solution of 50 mM HEPES, 100 mM NaCl, pH 7.5. 
Reconstituted protein was eluted with 3.5 mL of the equilibration buffer. The protein 
concentration was determined via the Bradford assay and the reconstitution of protein was 
confirmed by absorbance at 330 nm and 420 nm on a Cary WinUV spectrophotometer. 
For IscU and Isa1 [78], 200 μM apo protein was incubated with 50 mM DTT, argon purged 
for 30 min, and then made up to 1 mM in Fe2+ and 1 mM in S2-. After incubation for 1 h, 
the reaction mixture was concentrated and passed through a PD10 desalting column to 
remove excess of Fe2+ and S2-, and the UV-vis spectrum was obtained for both apo and 
holo IscU and Isa1. 
 
2.2.8 Reconstitution Analysis by Circular Dichroism 
CD scans of apo and holo proteins were recorded on a JASCO J-815 CD spectrometer in a 
quartz 1 cm anaerobic cuvette. CD scans from 300 nm to 600 nm were collected to analyze 
signature cluster-bound protein peaks at a scan rate of 200 nm/min at 25 °C. Data were 
processed using JASCO Spectramanager II Analysis software and were represented in 
Origin 7.0.  
2.2.9 Oligomerization State Determination by analytical ultracentrifugation (AUC) 
Apo G208C NFU1 at 50 μM protein (OD280 = 1.0), in the presence or absence of 1 mM 
TCEP, was loaded into the ultracentrifugation chambers and sealed, using 50 mM HEPES, 
100 mM NaCl, pH 7.5 as a reference, with the addition of 1 mM TCEP where needed. 
Reconstituted holo G208C NFU1 at 269 μM (OD420 = 1.5) was loaded in the same manner 




reach complete sedimentation. The sedimentation profiles were fit using SEDFIT to the 
Lamm equation [79,80]. 
 
2.2.10 [Fe2S2](GS)4] Synthesis 
The cluster used was synthesized as previously reported [30]. Briefly, ferric chloride (20 
mM) and sodium sulfide (20 mM) were added to 10 mL 40 mM glutathione solution, pH 
8.6. A volume (40 mL) of ethanol was added to the mixture and mixed by vortexing. The 
precipitate was collected by centrifugation at 13,000 rpm for 10 min, washed twice with 
ethanol and dried under vacuum. 
 
2.2.11 Iron Quantitation [78,81] 
A solution of [Fe2S2](GS)4 (0.05 mM, 200 μL) in H2O or holo protein was acidified by 
concentrated HCl (60 μL) and heated to 100 ºC for 15 min. The resulting suspension was 
centrifuged at 14,000 rpm for 2 min and the supernatant (100 μL) was diluted with Tris-
HCl (0.5 M, 1.3 mL, pH 8.5). Solutions of sodium ascorbate (0.1 mL, 5%) and 
bathophenanthroline-disulfonate (0.4 mL, 0.1%) were sequentially added to the 
neutralized reaction solution with mixing between each addition. The solution was 
incubated at 25 ºC for 1 h and iron was quantitated by measuring the absorbance at 535 
nm on a UV-Vis spectrophotometer and calculated from a calibration curve made with 
0.01-0.2 mM FeCl3 standard solutions (Fig. S1). 
 




The ability of NFU1 to take up an iron-sulfur cluster from the [2Fe-2S](GS)4 complex 
was examined by circular dichroism (CD). CD scans were recorded on a JASCO J-815 
CD spectrometer in a 1 cm anaerobic quartz cuvette from 600 – 300 nm at a scan rate of 
200 nm/min at 25°C, with a 2 min interval between each accumulation. NFU1 (50 μM) in 
50 mM HEPES, 100 mM NaCl pH 7.5, was thoroughly degassed in the presence of 5 
mM DTT and transferred to the anaerobic cuvette. Solid [2Fe-2S](GS)4 was resuspended 
in degassed 50 mM HEPES, 100 mM NaCl pH 7.5 and added to the argon-purged 
anaerobic cuvette via a gas-tight syringe to a final concentration of 400 μM to initiate the 
reaction. Data were processed using JASCO Spectramanager II Analysis software and 
analyzed in Origin 7.0. The deconvolution function from Spectramanager II analysis 
software was used for analysis of bands in the spectra that contained overlapping 
Lorentzian curves having the same full width at half maximum value that accurately 
distinguishes the peak positions for each band. 
 
2.2.13 Kinetics of Fe-S cluster extraction from holo NFU1 by glutathione  
Glutathione has been previously shown to extract the iron-sulfur cluster from various holo 
proteins to form the [2Fe-2S](GS)4 complex by monitoring the change in the charge 
transfer bands at 330 nm and 420 nm by UV-Vis spectrophotometry [26,30] . As was done 
for native holo NFU1 [28], degassed, reconstituted holo G208C NFU1 in 50 mM HEPES, 
100 mM NaCl, pH 7.5 was incubated with a 4- to 10-fold excess of GSH in an anaerobic 
cuvette and the absorbance at 420 nm on a Cary Win UV spectrophotometer was monitored 




time and fit to an exponential decay to obtain the kobs. A control reaction for holo G208C 
NFU1 in the absence of excess GSH was carried out under the same conditions to account 
for inherent cluster instability. Cluster extraction by GSH to form the [2Fe-2S](GS)4 
complex was confirmed using ESI mass spectrometry on a Bruker Micro-TOF (ESI) 
spectrometer and data was analyzed by use of DataAnalysis software (Bruker)  [30,82]. 
 
2.2.14 Kinetic cluster transfer experiments  
Kinetic cluster transfer experiments were designed based on the cluster transfer 
experiments  by Johnson and coworkers [83,84], and refined by our own group [26,28]. 
Reactions were performed on a JASCO J-815 CD spectrophotometer in a 1 cm anaerobic 
quartz cuvette from 600 – 300 nm at a scan rate of 200 nm/min at 25°C, with a 2 min 
interval between each accumulation. Reactions that reached completion within the first 10 
min were analyzed over a 10 nm wavelength scale based on the peak of interest with 10 
second intervals between accumulations. Spectra were processed using JASCO 
Spectramanager II Analysis software and were represented in Origin 7.0.  
Reactions in 50 mM HEPES, 100 mM NaCl, pH 7.5 were prepared by degassing a mixture 
of 40 μM apo protein in 5 mM DTT, and transferred to an anaerobic cuvette via a gas tight 
syringe. For reactions with the co-chaperone system, 22 μM HSPA9 and 22 μM Hsc20 
were included. MgCl2 (40 mM) and ATP (2 mM) were degassed separately and added 
immediately before addition of holo IscU [84-88]. Degassed holo protein at 40 μM was 
added to the cuvette to initiate the reaction. The concentration of [2Fe-2S] in the reaction 




Kinetics of cluster transfer was analyzed by converting the change in CD signal to the 
percentage of cluster transferred fit using DynaFit [89] to determine the second-order rate 
constants for the various reactions by best-fit simulation to second-order kinetics. 
 
2.3 Results 
Given the drastic cellular consequences of the G208C mutation on NFU1, we hypothesized 
that there could be two major contributors to protein impairment. Since cellular studies 
have shown that the protein is present at normal levels [32,38], the protein could be 
compromised in terms of its structural composition and recognition by partner proteins.  
Alternatively, it may be unable to perform functionally due to an inability to bind, receive 
or deliver an Fe/S cluster. By use of in vitro biochemical assays we set out to explore both 
possibilities.  
 
2.3.1 Structural Alteration of G208C NFU1 
2.3.1.1 G208C substitution does not significantly impact secondary structure 
Much has been reported concerning the domain organization and protein stability of the 
recombinant native human NFU1 [49,51], which provided a firm benchmark for study of 
the effect of the G208C substitution on human NFU1 with regard to structural and stability 
characterization, relative to the native protein. Secondary structure and stability was 
examined via variable temperature circular dichroism (VTCD) and comparison of the 
melting profiles and thermodynamic characteristics of the native human NFU1 and the 




parameters (Table 1) and yielded a satisfactory fit.  Interestingly, the G208C NFU1 
derivative shows a VTCD trace very similar to that of the native, with the mutant protein 
and the native exhibiting the same melting temperature within error, indicating that the two 
proteins are actually similar in their stabilities. Combining the VTCD data with an 
additional stability measurement, limited proteolysis (Fig. S2), we observe that the two 
proteins are both fairly equal in terms of stability, consistent with our other data. Both 
proteins exhibited reversible melting on VTCD (data not shown), indicating that the overall 
protein folds are relatively stable. Melting data were also fit to a two-state model (Fig. 2), 
due to the multidomain nature of the protein, which has been previously characterized [49].  
However, the two-state model did not yield any interpretable improvements to the fit and 
was not considered further.  
Circular dichroism was also used to examine the overall characteristics of protein 
secondary structure by determining the percentages of secondary structural elements: α-
helix, β-sheet and random coil. The values are summarized in Table 2 and demonstrate an 
overall increase in random coil and loss of secondary structural elements; however, the 
modest change in secondary structural elements has not impacted protein stability based 
on the one-state VTCD results (Fig. 2; Table 1) and limited proteolysis (Fig. S2).  
 
2.3.1.2 G208C substitution impacts tertiary structure by promoting dimerization 
To clarify the results obtained via VTCD and extend the stability comparison to tertiary 
structural elements, Differential Scanning Calorimetry (DSC) was used to examine the 




of the protein in comparison to the native. The DSC profile of native human NFU1 (Fig. 
3A) matches the parameters determined in prior literature [49] in that the protein follows 
a two-state melting process with  Tm1 of 59.4 ± 0.20 °C and a second melting event at 
72.6 ± 0.04 °C (Table 3). The lowest Tm value for native protein corresponds to the 
melting of the C-terminal domain and the higher melting temperature represents the 
melting of the well-folded N-terminal domain [49]. The DSC profile for the G208C 
derivative interestingly exhibited a three phase melting process (Fig. 3B): the first broad 
melting peak is indicative of the molten globular C-terminal domain with Tm1 of 49 ± 6 
˚C, a second sharp peak not seen in the native melting profile with Tm2 of 64 ± 2 ˚C and 
an additional shoulder from the structured N-terminal domain with Tm3 of 74 ± 4 ˚C 
(Table 3).  The similarity of melting temperatures and van’t Hoff enthalpies (within error) 
for the transitions in the substituted protein, relative to the native NFU1 (Table 4), 
confirm the comparable stabilities of each. 
Previous DSC analysis of human NFU1 ascribed the two peaks in the melting trace as 
arising from C-terminal domain unfolding at low temperature, due to its molten globular 
nature, and N-terminal domain unfolding at higher temperature [49,51].  For this reason, 
the presence of a third peak in the DSC trace for G208C NFU1 was quite surprising. An 
additional protein domain could not have been introduced by the point mutation, so we 
sought to understand the origin of the new peak by application of analytical 
ultracentrifugation (AUC) to examine oligomerization effects. AUC was completed for 
apo G208C NFU1 in the presence and absence of 1 mM TCEP to eliminate the potential 




monomer was observed at 22.6 kDa (expected MW: 23.9 kDa) as 29% of the total 
observed species (Fig. 4, black).  Dimer at 41.6 kDa accounted for 58%, and some higher 
order oligomer at 74.0 kDa, potentially corresponding to a tetrameric form, constituted 
6% of the sample.  However, in the presence of 1 mM TCEP (Fig. 4, red), monomer was 
still observed at 22.9 kDa, accounting for 30%.  The percent of dimer at 41.9 kDa, was 
also practically unchanged at 60%. The largest change observed was for the higher order 
oligomeric species. A species at 83.5 kDa was observed as ~ 1.5% of the total species. 
The apo protein percentages contrast sharply with the AUC data collected for the native 
protein, which showed the monomer and dimer in approximately equal percentages [28], 
suggesting that the point mutation propagates the protein’s tendency to oligomerize, but 
not via disulfide bonding and could explain the additional melting peak present in the 
DSC trace. However, the apparent modest decrease in thermodynamic stability and 
increased propensity towards dimer formation does not alter the protein’s susceptibility to 
degradation in limited proteolysis (Fig. S2), reducing the likelihood that the point 
mutation initiates a major structural change of the protein.  The mutant protein is not 
significantly less stable than the native form; however, the minor structural changes from 
secondary structure composition seem to promote a greater tendency to dimerize, and 
these perturbations may have large impacts on function and partner recognition. 
 
2.3.2 Functional Impairment of G208C NFU1 




Following the thermodynamic and structural comparisons of G208C NFU1 with the native 
protein, we next examined the functional changes resulting from the mutation in order to 
link the oligomeric changes to the downstream effects. Similar to the native protein, G208C 
NFU1 could be reconstituted in vitro by use of Tm NifS and L-cysteine, and yielded a UV 
spectrum with typical iron-sulfur cluster charge-transfer bands at 330 and 420 nm (Fig. 5A, 
blue trace). However, in contrast to the native protein, which cannot be reconstituted with 
inorganic sulfide, G208C NFU1 was found to be readily reconstituted with ferric chloride 
and sodium sulfide to yield a native-like UV spectrum and a slightly more prominent 420 
nm signature (Fig. 5A, green trace). Additionally, both reconstitution methods resulted in 
similar UV and CD spectra relative to native NFU1, although with a slight increase in 
intensity at certain wavelengths (Fig. 5). Inasmuch as native human NFU1 has been shown 
to bind a [2Fe-2S] cluster under enzymatic reconstitution conditions [28], the similarity in 
UV and CD spectra suggests that the G208C mutant is capable of binding the same type of 
cluster. Based on iron quantitation, reconstitution via sodium sulfide resulted in the highest 
maximum yield, with 0.86 [2Fe-2S] cluster/dimer, while reconstitution with L-cysteine 
gave 0.76 [2Fe-2S] cluster/dimer. However, both of these yields are in line with what has 
been typically achieved for the native protein, which yielded 0.75 [2Fe-2S] cluster/dimer 
[28]. Therefore, the G208C mutant is capable of binding an iron-sulfur cluster and in a 
similar environment to the native form. Protein oligomerization around the cluster was 
confirmed via AUC. Holo G208C was monitored at 420 nm to measure the cluster-bound 
form of the protein. The majority (65.6%) of the holo protein exists as a dimer with a minor 




more tetramer than dimer. For both the native and the mutant, no clear additional peaks 
were observed in the AUC trace [28,58]. The remaining percentages correspond to protein 
aggregation and crashing out. The G208C mutation alters the ability of NFU1 to 
oligomerize in both the apo and holo forms relative to native protein.  These data are 
confirmed by the AUC of the holo protein at 280 nm (Fig. S3A).  
 
2.3.2.2 G208C NFU1 cannot take up Fe/S clusters from relevant donor sources 
Our previous analysis of native human NFU1 [28] has shown that the human protein was 
capable of receiving and transferring cluster from other Fe/S proteins, as well as from a 
physiologically relevant glutathione-bound iron-sulfur cluster complex [2Fe-2S](GS)4. 
This complex can be delivered to a number of iron-sulfur cluster proteins [26,30] and is a 
viable substrate for the mitochondrial ABCB7 transporter [29,82], suggesting a possible 
role for the [2Fe-2S](GS)4 complex as a component of the labile iron pool. Native human 
NFU1 can take up a [2Fe-2S] cluster from the complex with a second-order rate constant 
of 1930 M-1min-1 [28], as observed by circular dichroism (CD). However, G208C NFU1 is 
unable to take up a cluster from this complex, even with an 8-fold excess of the complex 
(data not shown).  
Likewise, G208C NFU1 was unable to receive a Fe/S cluster from donor proteins. We have 
previously demonstrated that [2Fe-2S] cluster proteins are able to transfer an iron-sulfur 
cluster to native human NFU1 [27,90]. Therefore, we have examined the ability of the 
G208C mutant protein to be reconstituted in the same way using CD spectroscopy. Holo 




observed that would represent the unique spectrum of holo G208C NFU1 (Fig. 5B), 
indicating that human IscU is incapable of transferring cluster into G208C NFU1 (data not 
shown). Because involvement by Hsc co-chaperones has been implicated in IscU-
promoted cluster delivery to target proteins [22,25,44], we also examined the kinetics of 
transfer from holo human IscU to apo human NFU1 and G208C NFU1 in the presence of 
HSPA9, Hsc20, MgCl2 and ATP.  With the chaperones, IscU was unable to transfer cluster 
in to either the native or the mutant (Fig. S4), even though transfer from IscU to the native 
protein can proceed without the chaperone system [90]. Similarly, we monitored the ability 
of S. pombe Isa1 to transfer a cluster into G208C NFU1, since that transfer was also 
observed for native NFU1 [27]; however, the appearance of the G208C NFU1 signature 
peaks was not observed, even over the course of 3 h (data not shown). Minor peak shifts 
were seen, but the overall signal mainly resembled Isa1, indicating possible formation of a 
heterodimeric complex. Nevertheless, no clear transfer was demonstrated from Isa1 to 
G208C NFU1. All of the donor sources for cluster that we examined were unable to 
reconstitute G208C NFU1 with an Fe/S cluster. 
 
2.3.2.3 Chemically Reconstituted G208C NFU1 can still transfer Fe/S clusters to target 
proteins, albeit with perturbed second-order rate constants 
Our previous work with the native form of NFU1 has characterized aspects of NFU1 in 
Fe/S cluster delivery and trafficking. As such, the [2Fe-2S](GS)4 complex could be formed 
by cluster extraction from the [2Fe-2S] cluster-bound native NFU1 under conditions of 




Excess GSH is also able to extract the [2Fe-2S] cluster from holo G208C NFU1, and the 
decrease in absorbance at 420 nm was monitored over the course of an hour (Fig. 6A, red 
trace). The decrease in absorbance was not due to cluster breakdown on G208C NFU1, 
since a control in the absence of excess GSH (Fig. 6A, black trace) demonstrated very little 
change in absorbance. The change in absorbance data was determined at four different 
GSH concentrations and kobs was calculated from each concentration. The data were fit to 
a linear equation to determine the overall second-order rate constant for GSH extraction of 
140 ± 20 M-1min-1 (Fig. 6B), which is in the same range as the second-rate constant found 
for the native protein, indicating that dimerization has not influenced the ability to transfer 
a cluster out of G208C NFU1 to this target. Extraction of the cluster by GSH to form the 
[2Fe-2S](GS)4 complex was confirmed by appearance of the cluster m/z peak of 1427.3 in 
ESI-MS, which corresponds to an adduct of the complex with one sodium [30,82] (Fig. 
S5). 
G208C NFU1 is also capable of transferring the [2Fe-2S] cluster to other apo protein 
targets. As found for native human NFU1, cluster transfer to ferredoxins 1 and 2 (Fdx1 
and Fdx2) [28] and glutaredoxins 2 and 3 (Grx2 and Grx3) was observed [27]. Cluster 
transfer was monitored by use of CD spectroscopy because unique spectra are generated 
for each iron-sulfur cluster bound protein [91]. Although some these previous transfer 
reactions were not carried out in the preferred pseudo first-order kinetics range, as a 
result of limitations from detection sensitivity and protein solubility, we have developed a 
method to provide estimates for second-order rate constants in cluster transfer reactions 




have shown in test cases that the apparent second-order rate constant obtained in this 
manner shows close agreement with the rate constant determined from more traditional 
concentration dependence measurements [26,28].  Herein, we have used those same 
methods to determine apparent second-order rate constants for mutant NFU1 for 
comparison with the native transfer rates. Reconstituted holo G208C NFU1 was added to 
apo human Fdx1 and the increase in CD signal at 445 nm was monitored (Fig. 7A and 
7B) and used to yield a second-order rate constant for the transfer of [2Fe-2S] cluster of 
2600 ± 300 M-1min-1.  Similarly, cluster transfer from G208C NFU1 to human Fdx2 
yielded an overall second-order rate constant of 1200 ± 200 M-1min-1 (Fig. 7C and 7D). 
Cluster transfer kinetics for transfer to glutaredoxins was executed in the same manner as 
for the ferredoxins. Following addition of holo reconstituted G208C NFU1 to either apo 
Grx3 or apo Grx2, the change in CD signal was monitored. Since the glutaredoxins utilize 
glutathione as endogenous ligands, an excess of GSH was included in the reactions to be 
able to reconstitute a functional glutaredoxin protein. The [2Fe-2S](GS)4 complex is CD 
silent [30]. Given that no intermediate spectra were observed during the transfer from either 
native NFU1 or G208C NFU1 to glutaredoxins, the data is consistent with direct cluster 
transfer to the putative partner protein with no intermediate species formed by extraction 
of the cluster to form a transitory complex.  In both cases, rapid transfer was observed such 
that by the end of 2 min the spectra already resembled those of the target holo proteins. For 
that reason, cluster transfer kinetics were monitored over 10 sec intervals, instead of 2 min 
intervals. Transfer to apo human Grx2 was also complete within the first 15 min (Fig. 8A 




resulted in a large second-order rate constant of 22400 ± 5000 M-1min-1. Cluster transfer 
from holo G208C NFU1 to apo S. cerevisiae Grx3 (Fig. 8C and 8D) was complete within 
the first 15 min and yielded a second-order rate constant of 14500 ± 3500 M-1min-1.  
G208C NFU1 was capable of delivering a [2Fe-2S] cluster to the same target proteins that 
have been examined for kinetic transfer from the native form. However, the rates of these 
transfer reactions are significantly different, especially when examining interactions with 
the glutaredoxin proteins.  
 
2.4 Discussion 
Previously we have examined and characterized the iron-sulfur cluster protein NFU1 in 
terms of its stability and iron-sulfur cluster binding and transfer capabilities [28,50,51] . 
Based on our findings from studies of the native human protein, we decided to investigate 
an important disease-causing mutation of NFU1. A genetic point mutation converts a 
glycine at position 208 of the amino acid sequence to a cysteine (G208C), resulting in the 
disease condition known as Multiple Mitochondrial Dysfunctional Syndrome 1 (MMDS1), 
where symptoms primarily result in death during the infant stage of life [32,38]. 
Accordingly, to better determine the cause of the human disease phenotype and understand 
its molecular basis, we have characterized the stability and iron-sulfur cluster binding and 
transfer capabilities of the substituted G208C NFU1 protein. Given our two potential 
hypotheses for the disease phenotype (altered protein structure and recognition, or 
perturbation to Fe/S cluster uptake or transfer), we began with an examination of protein 




characteristics. Initial analysis via VTCD demonstrated no significant change in secondary 
structure thermodynamics, suggesting that the native and mutant forms of NFU1 are 
relatively similar. However, modest changes were observed in secondary structure 
composition and DSC traces.  G208C NFU1 exhibited an overall increase in random coil 
(Table 2), which does not demonstrate significant effects on stability. The major structural 
or stability impacts are reflected in the DSC trace, in conjunction with AUC, to show an 
increased tendency of the protein to oligomerize, specifically to the dimeric form.  
The DSC trace of the mutant protein showed a new melting peak (Fig. 3A and 3B), relative 
to the recombinant native protein, which is consistent with a modest change in secondary 
structure that could perturb the dimerization interface.  Examination by AUC showed that 
the dimer was present in the majority (Fig. 4), which contrasts with the more equal 
distribution of monomer and dimer for the native protein [28], suggesting the monomer-
dimer equilibrium for apo to be skewed in the direction of dimer. The increased 
concentration of dimer could affect the DSC trace by altering the melting process. For the 
native protein, the unfolding of the dimer is concurrent with the melting of the molten 
globular C-terminal domain to yield a partially unfolded monomer [92,93], as observed by 
the first transition in Figure 3A. Following this concerted melting process, the remainder 
of the protein melts to yield completely unfolded monomers, represented by the three-state 
mechanism shown in equation 2. However, G208C NFU1 exists primarily as a dimer, 
which shifts the unfolding process to exhibit a new and distinct melting peak in the DSC 
trace. The mechanism (equation 3) would now be reflective of a four-state melting process, 




to melt (the first transition of three), reducing dimer stability and causing the dimer to 
unfold in the second melting event (Fig. 2B) [92,93]. Lastly, the N-terminal domain melts 
to complete the unfolding process, just as it had for the native. 
Equation 2 Two-Phase Unfolding Process 




↔ 2(𝑁𝑈𝐶𝑈)     
Equation 3 Three-Phase Unfolding Process 






↔ 2(𝑁𝑈𝐶𝑈)      
                                            (U – represents unfolded protein) 
 
Since the DSC and secondary structure data suggested a change in structure for the mutant 
protein, we submitted the protein sequence to Phyre2 [94] for structure prediction by 
homology modeling, which utilized the NMR structure of the C-terminal domain of mouse 
NFU1 (PDB ID: 1VEH) and the NMR structure of the C-terminal domain of human NFU1 
(PDB ID: 2M5O) to generate a model for G208C NFU1. The resulting model predicts that 
the placement of the cysteines will change with the mutation (Fig. 9). The CXXC domain 
exists as a flexible loop, while the G208C NFU1 protein has an altered loop, which appears 
to lock the position of the C at residue 213 as the beginning of an α-helix (Fig. 9). The 
replacement of the flexible glycine [95], with a more rigid cysteine has altered the cluster 
binding loop such that the overall structure of the protein has changed, and could promote 
an interaction interface to support an increase in the presence of dimers, although how this 




Inasmuch as the investigation of the biochemical consequences of the G208C substitution 
demonstrate a structural change that promotes dimerization, but no major change in protein 
stability, we next examined how this mutation and its structural perturbations would impact 
function. Our studies of native NFU1 demonstrated a bound [2Fe-2S] cluster that can be 
transferred in and out of the protein by interactions with either other iron-sulfur cluster 
proteins or a physiologically relevant [2Fe-2S](GS)4 complex [28]. Similarly, the G208C 
NFU1 derivative was capable of undergoing reconstitution in vitro through the use of either 
sodium sulfide, or L-cysteine with Tm NifS as a sulfide source (Fig. 4), while native NFU1 
can only be reconstituted using L-cysteine with Tm NifS; however, reconstitution yields in 
all cases were similar. Following reconstitution, both UV and CD spectra look analogous, 
indicating the presence of a similarly bound [2Fe-2S] cluster. The cluster on holo G208C 
NFU1 was stable over the course of an hour and remained bound to the protein even in the 
presence of 5 mM DTT (Fig. S6).  
Although G208C NFU1 was capable of being reconstituted using in vitro methods, the 
protein was unable to accept cluster from other physiologically relevant sources, and most 
likely reflects deficiencies in reconstitution expected inside the cell.  Also, in contrast to 
native protein, the G208C variant is unable to take up the [2Fe-2S](GS)4 complex [28]. 
Likewise, the mutant protein is unable to receive a [2Fe-2S] cluster from typical iron-sulfur 
scaffold proteins such as Isa1 and IscU (Table 5), which have been shown to deliver a 
cluster into native NFU1 [27,90]. Current models for Fe/S cluster biogenesis indicate that 
transfer from IscU is promoted with assistance from heat shock chaperone proteins 




NFU1 does not occur in the presence of the chaperones (Fig. S4), which is similar to 
transfer from holo human IscU to apo ferredoxin 2 (Fig. S7) or ferredoxin 1 [87], where 
transfer is unaffected in the case of the former, and inhibited for the latter, in the presence 
of chaperones. Inhibition most likely arises from stabilization of the cluster on holo IscU 
[87] that slows its ability to transfer the cluster. In the case of transfer to human NFU1 in 
the presence of chaperones, we postulate that no transfer is observed, at least on the time 
scale considered, due to possible steric interaction of NFU1 with the chaperone proteins 
[58,97] in conjunction with the stabilization of cluster on IscU. 
Heat shock chaperones are highly conserved across bacteria, yeast and humans, and serve 
crucial roles in Fe-S cluster biogenesis, mediating cluster delivery to key targets such as 
glutaredoxins and succinate dehydrogenase [22,98].  As such, they have been studied in all 
of those organisms.  Moreover, because the process of Fe-S cluster biosynthesis is highly 
conserved, the co-chaperone system is believed to play similar roles across various 
organisms, however, minor kinetic differences have been observed when making 
comparisons between organisms. For example, heat shock chaperones are observed to 
greatly increase the rate of transfer from IscU in Azotobacter vinelandii (22-fold to Fdx 
and 670-fold to Grx5) [84,88] and on a more minor scale (5-10 fold) in E. coli [85,86], but 
have actually been shown to slow a transfer reaction in humans [87]. The observed 
differences in rate enhancement across these organisms suggest that the chaperone systems 
could participate in distinct roles in support of Fe/S cluster biogenesis and/or trafficking, 




block IscU-mediated cluster delivery to NFU1 (Table 5), but serves no clear role in rate 
enhancement in subsequent delivery to Fdx’s (Table S1).     
Since the mutant form of NFU1 cannot receive cluster from traditional sources, in contrast 
to the native protein (Table 5), this readily explains the detrimental phenotype and 
symptoms observed for those with the point mutation.  Derivative G208C NFU1 not 
receive a cluster in vivo and would therefore be unable to transfer a cluster to downstream 
partners. The predicted change in structure (Fig. 9), suggesting that the CXXC loop in 
G208C NFU1 has been locked into a specific orientation, may align the cysteines in such 
a way that they no longer exhibit the conformational flexibility required for cluster uptake 
and reconstitution in the cell. Alternatively, the increased proportion of dimeric protein 
could sterically block the CXXC motif from cluster uptake. In either case, the protein 
cannot accept a pre-formed [2Fe-2S] cluster, since cluster assembly on G208C NFU1 is 
observed only under in vitro reconstitution conditions employing inorganic iron and 
sulfide. In addition to the possibility of impaired accessibility of the CXXC cluster binding 
motif, the replacement of a glycine with a cysteine near the cluster binding site could 
perturb cluster coordination, where the new cysteine now functions as a cluster ligand. This 
alternative is currently under investigation to determine if the CXXC motif is solely 
responsible for cluster coordination even with the added cysteine in the new CXCXXC 
sequence.   
The inability of the mutant protein to receive cluster from relevant sources shows good 
correlation with the increased presence of dimer. In our examination of the native NFU1, 




monomeric [28]. Kinetic assays for cluster uptake have revealed a model consistent with 
experimental data, where the cluster is taken up first by a monomer of NFU1, followed by 
formation of complete holo NFU1 when a second monomer is added to form the [2Fe-2S] 
cluster-bound dimer (Fig. 10). Cluster uptake into a preformed dimer did not occur and 
was not supported experimentally [28].  Since the mutant is primarily in the dimer form, 
the oligomeric state would prevent cluster uptake into G208C NFU1. A similar mechanism 
for cluster transfer from other holo proteins is most likely in place, where dimer formation 
is preventing G208C NFU1 from efficiently receiving cluster (Figure 10). A model, in 
which the monomeric form of NFU1 is the active species, is consistent with the emerging 
evidence for a functional NFU1-BolA complex involved in Fe/S cluster biogenesis [60,99], 
due to the fact that NFU1 would need to be capable of forming cluster-bridged homo- and 
heterodimeric species. 
The structural change promoting dimer formation and the downstream consequences of 
this oligomerization could explain the dominant negative phenotype recently observed by 
introducing the MMDS1 mutation in yeast [60]. In utilizing yeast as a model system, 
Melber and colleagues introduced the MMDS1 mutation and found that co-expression of 
wild-type yeast Nfu1 could not rescue the effects [60]. Having a mutation that promotes 
protein oligomerization, thereby preventing cluster uptake and downstream transfer, 
readily explains this phenotype. Native human NFU1 has a natural tendency to dimerize 
[28] and the G208C mutation amplifies this characteristic. Therefore, it is plausible that a 
mixture of native and mutant Nfu1, such as in the co-expression system mentioned above, 




monomeric and dimeric states, the mutant would be primarily dimeric, and heterodimers 
could be formed between the native and the mutant monomeric proteins. With all of the 
dimers present, cluster uptake would be impaired and downstream cluster transfer 
perturbed, as we have shown here.  
These kinetic limitations and alterations to the Fe/S biosynthesis pathway could generate 
the drastic consequences and the dominant negative phenotype. However, yeast is not the 
best model for human NFU1 concerning the MMDS1 condition. Yeast Nfu1 has been 
observed to behave differently from human NFU1 inasmuch as deletion of Nfu1 is not 
lethal [100], and negative effects are only exhibited when grown on specific media, which 
may be reflective of a conditional need for Nfu1 in yeast with a bypass mechanism in place 
to allow for survival [60]. Furthermore, introduction of the G208C equivalent mutation in 
yeast results in functional consequences that are not observed in patients, such as aconitase 
depletion [60].  Together, these differences may speak to potentially dissimilar functions 
across yeast and human Nfu-type proteins [60], indicating that these types of studies need 
to be addressed in an in vivo system that better replicates the MMDS1 disease condition in 
conjunction with in vitro studies, which are unique in being able to address issues at the 
molecular level, such as the dimerization effect.  
While G208C NFU1 does not appear to have a mechanism of efficient in vivo 
reconstitution, the derivative did retain cluster transfer activity and was able to deliver 
clusters to both human ferredoxin 1 and 2 (Fig. 7), at a modest rate of approximately half 
of the second-order rate constant observed for the native protein (Table 5) [28]. A greater 




glutaredoxins (Fig. 8). The point mutation results in a changed preference for the 
glutaredoxins. Our previous work has indicated that [2Fe-2S] cluster from native NFU1 to 
apo Grx3 was a kinetic sink at 36000 M-1min-1, while transfer to Grx2 occurred, but at 
around the same level as other transfers from NFU1 (Table 5) [27,90]. However, the mutant 
form of the protein now kinetically prefers cluster transfer to Grx2 by increasing the 
second-order rate constant seven-fold over transfer to Grx3, which decreased by three-fold. 
Although Grx2 is primarily present in the mitochondria [101], where Grx3 is cytosolic 
[102], the large change in second-order rate constants reflects a kinetically altered iron-
sulfur cluster transfer pathway due to a single point mutation, which, again, could suggest 
why such severe phenotypes are observed, as there could be drastic downstream 
consequences for minor perturbations to the transfer pathway.  
MMDS1 was only recently identified as a disease condition, with the first case studies 
emerging in 2011 [32,38]; however, the number of patients diagnosed with MMDS1 due 
to the G208C NFU1 mutation has been growing since its initial disease classification. At 
least 22 patients have been diagnosed since 2011 [32,38,45,46], but it is speculated that 
this is a highly underdiagnosed condition [46]. Patient case studies describing the same 
symptoms and disease characteristics, which were attributed to defects in the iron-sulfur 
cluster biosynthetic pathway, were first published in 2001; [103] but, in the absence of 
information provided by the human genome project, the exact cause of the disease 
remained unclear, suggesting the first subset of under-diagnosis. Furthermore, the disease 
symptoms resemble the majority of mitochondrial or energetic disorders and the patients 




been investigated in depth and the number of cases of MMDS1 is likely to be much higher 
[46]. Since the disease has only been examined recently, it is also possible that the majority 
of downstream target proteins for NFU1 that result in the severity of the disease condition 
are unknown.  
Our investigation into the G208C NFU1 mutation has elucidated key facts regarding the 
actual structural and functional impairments caused by the mutant NFU1 in MMDS1. 
While several questions remain to be answered, such as the exact link between NFU1 and 
lipoic acid synthase or succinate dehydrogenase [38,63], we postulate that the mutation 
alters the structure of the NFU1 protein such that the protein exists in a primarily dimeric 
state, which prevents it from being able to be reconstituted effectively with an iron-sulfur 
cluster in vivo. The kinetics of [2Fe-2S] cluster transfer have been perturbed due to the 
mutation, but the connection between the mutant NFU1 and how it interacts with other 
potential target proteins remains under investigation.  
 





Figure 2-1. (A) A representation of the two-domain composition of the native and G208C 
mutant NFU1 proteins 
with the N-terminal domain in blue and the C-terminal domain in red. NFU1 features the 
functional CXXC Fe/S cluster binding motif in its C-terminal domain. This pattern is 
altered in the mutant protein with the mutation of a nearby glycine residue at position 208 
to cysteine, which gives a CXCXXC motif. (B) Solution NMR structure of human C-
terminal domain of the NFU1 protein (PDB ID: 2M5O) with the cluster binding cysteines 
shown in yellow [58]. The glycine at position 208 in the full-length protein (58 above), 
which is mutated to a cysteine in MMDS1, is colored red. Numbering is consistent with 










Figure 2-2 VTCD traces  
for the melting of 10 μM native human NFU1 (A) and G208C NFU1 (B) in 40 mM 
phosphate, pH 7.4. Data were fit to equation 1 to obtain Tm and ΔHV, which are shown in 
Table 1. CD units of ellipticity (mdeg) were used directly without conversion to molar 
ellipticity because the van’t Hoff enthalpies are independent of such a factor [49].  
 
 
Figure 2-3 Differential scanning calorimetry profiles  
for (A) 0.2 mM native human NFU1, (B) 0.3 mM G208C human NFU1. Both of the 
proteins were in 50 mM HEPES, 100 mM NaCl, and pH 7.4. The data were fit using Origin 
7.0 to obtain Tm, ΔHcal, and ΔHV, all of which are listed in Tables 3 and 4. 
 













































Figure 2-4 Analytical ultracentrifugation profiles for G208C NFU1.  
(A) Apo G208C was sedimented in the absence of TCEP (black) and in the presence of 1 
mM TCEP (red). Sedimentation was monitored at 280 nm. The first peak of the black trace 
at 22.6 kDa accounts for 29% of the sample, the second peak at 41.6 kDa accounts for 58%, 
and the third peak at 74.0 kDa accounts for 6%. The first peak of the red trace at 22.9 kDa 
accounts for 30% of the sample, the second peak at 41.9 kDa accounts for 60%, and the 
third peak at 83.5 kDa accounts for 1.5%. The AUC results were fit to the Lamm equation 
[79,80] using a continuous distribution model to obtain the peaks and molecular weights 
shown above. 
 























Figure 2-5 UV (A) and CD (B) spectra following reconstitution  
of native and G208C NFU1. In both spectra, the black trace corresponds to apo G208C 
NFU1, and the red trace to native reconstituted holo NFU1. In (A), the blue trace is holo 
G208C NFU1 reconstituted with Tm NifS and L-cysteine, while the green trace is holo 
G208C NFU1 reconstituted with ferric chloride and sodium sulfide. In (B), the blue trace 
is holo reconstituted NFU1, since both reconstitution methods resulted in the same spectra.  
 
 
Figure 2-6 GSH extraction  
of the [2Fe-2S] cluster from 10 μM reconstituted holo G208C human NFU1 to form the 




course of an hour and data were fit to an exponential to obtain the kobs. (A) Shows a 
representative trace of extraction by 1 mM GSH (red trace). The black trace shows a control 
of reconstituted holo G208C human NFU1 in the absence of GSH to demonstrate the rate 
of general cluster instability or breakdown. The concentration of GSH was varied, while 
keeping the concentration of G208C NFU1 constant to obtain a second-order rate constant. 
(B) The kobs data were plotted against the concentration of GSH and fit to a linear equation 
to determine an overall second-order rate constant of 140 ± 20 M-1min-1. 
 
 
Figure 2-7 Kinetics of [2Fe-2S] cluster transfer  
from holo reconstituted human G208C NFU1 to apo human ferredoxins. (A) Time course 
for cluster transfer to ferredoxin 1(Fdx1) monitored by CD in 50 mM HEPES, 100 mM 
NaCl, pH 7.5. Spectra were recorded every 2 min after the addition of holo NFU1, and 
converted to percent cluster transfer (B) to yield an apparent second-order rate constant 
from DynaFit of 2600 ± 300 M-1min-1 based on the concentration of the [2Fe-2S] cluster 




2 (Fdx2) recorded by CD under the same conditions as for Fdx1. (D) The CD signal was 
again converted to the percentage of cluster transferred with time to yield an apparent 
second-order rate constant of 1200 ± 200 M-1min-1. 
 
 
Figure 2-8. Kinetics of [2Fe-2S] cluster transfer  
from holo reconstituted human G208C NFU1 to apo glutaredoxins. (A) Time course for 
cluster transfer to apo human Grx2 monitored by CD in 50 mM HEPES, 100 mM NaCl, 
and pH 7.5 with 3 mM GSH. Spectra were recorded every 2 min after the addition of holo 
NFU1. However transfer was too rapid to monitor, so cluster transfer was monitored from 
435-445 nm every 10 sec and converted to percent cluster transfer (B) to determine an 
apparent second-order rate constant using DynaFit of 22400 ± 5000 M-1min-1 based on the 
concentration of the [2Fe-2S] cluster [89]. (C) Time course for cluster transfer to apo S. 
cerevisiae Grx3 monitored by CD under identical conditions. Again, cluster transfer was 




converted to percent cluster transfer (D) to determine an apparent second-order rate 
constant of 14500 ± 3500 M-1min-1. 
 
 
Figure 2-9 Alignment of the human C-terminal domain of the NFU1 protein  
(PDB ID: 2M5O) (green trace) and corresponding cysteines in red. The Phyre2 homology 







Figure 2-10 (A) A model for [2Fe-2S] cluster uptake by monomeric NFU1 
 represented by the N- and C-terminal domains, from the [2Fe-2S](GS)4 cluster complex 
to form an intermediate [2Fe-2S] species with two exogenous GSH ligands. A second 
monomeric NFU1 displaces the GSH molecules to form [2Fe-2S] dimeric NFU1. Adapted 
from [1]. (B) A model for [2Fe-2S] cluster uptake by monomeric NFU1, from a [2Fe-2S] 
cluster scaffold, such as IscU. Holo IscU interacts with monomeric NFU1 to form a 
transient heterodimeric complex. A second NFU1 monomeric displaces the now apo IscU 
to form the holo NFU1 dimer.  In a case where NFU1 is a pre-formed dimer (C), such as 
in the G208C mutant, the dimeric NFU1 is unable to form the transient complex with holo 
IscU and therefore unable to receive the [2Fe-2S] cluster. 
 
 
 Tm (°C) ΔHV (kcal/mol) 
Native NFU1 65 ± 1 26 ± 2 
G208C NFU1 65 ± 2 31 ± 2 
Table 2-1 Variable temperature circular dichroism results.  
Native NFU1 and G208C NFU1 at 10 μM were subjected to melting from 20 to 95 °C at 







 α-helix β-sheet Random Coil 
Native NFU1 47 % 21 % 33 % 
G208C NFU1 37 % 17 % 46 % 
Table 2-2. Percentages of secondary structural elements  
measured by circular dichroism and analyzed using the analysis program CDSSTR [73] on 
the online Dichroweb server [75,76]. 
 
 Tm1 (°C) Tm2 (°C) Tm3 (°C) 
Native  NFU1 59.3 ± 0.2 -- 73 ± 3 
G208C NFU1 49 ± 6 64 ± 2 74 ± 4 
Table 2-3. Melting temperatures as determined from DSC.  
















73 ± 2 41 ± 2 -- -- 122 ± 1 74 ± 5 
G208C 
NFU1 
5.2 ± 0.4 33 ± 4 39 ± 2 50 ± 2 24 ± 4 74 ± 4 
Table 2-4. Enthalpies of melting determined by DSC.  
The DSC profiles used for data fitting are shown in Figure 2.   
 
 Rate Constant for Native 
NFU1 (M-1min-1) 
Rate Constant for G208C 
NFU1 (M-1min-1) 
Human NFU1 to human Fdx1 4700 ± 800   [28] 2600 ± 300 
Human NFU1 to human Fdx2 3900 ± 1200  [28] 1200 ± 200 
Human NFU1 to human Grx2 3740 ± 77   [27] 22400 ± 5000 
Human NFU1 to S. cerevisiae Grx3 36200 ± 7700   [90] 14500 ± 3500  
S. pombe Isa1 to human NFU1 6700 ± 1560   [27] No transfer 
[2Fe-2S](GS)4 to human NFU1 1930 ± 210   [28] No transfer 




Human IscU to human NFU1 with 
HSPA9/Hsc20 and MgATP 
No transfer  No transfer 
Human NFU1 to GSH to form [2Fe-
2S](GS)4 complex 
130 ± 22   [28] 140 ± 20 
Table 2-5. Apparent second-order rate constants determined using CD for [2Fe-2S] 
cluster transfer to and from G208C NFU1.  





Chapter 3 : Understanding the Molecular Basis for Multiple Mitochondrial Dysfunctions 
Syndrome 1 (MMDS1): Impact of a Disease-Causing Gly189Arg Substitution on 
Structure and Activity of NFU1 in the Fe/S Cluster Biosynthetic Pathway 
 
3.1 Introduction 
Study of novel proteins and their behavior in disease states has often led to elucidation of 
their function in vivo. For example, although a clinical description of cystic fibrosis was 
outlined in the 1930s, it was not until the 1980s that genetic analysis implicated mutation 
on chromosome 7, now known as the cystic fibrosis transmembrane conductance regulator 
(CFTR) gene, as the etiological factor of cystic fibrosis. The discovery then led to an in-
depth analysis of the protein and its polymorphisms to understand its function and role in 
disease [104]. Similarly, an investigation of thiazolidinedione binding, a class of drugs 
used to treat type 2 diabetes, led to discovery of a novel integral mitochondrial protein 
mitoNEET, which is now thought to have a key role in regulation of electron transfer and 
oxidative phosphorylation and potentially contribute to the etiology of type 2 diabetes 
[105,106]. Discovery of these proteins and examination of their function has guided 
ongoing efforts for drug development and disease cure.  
Likewise, a fatal mitochondrial disease, multiple mitochondrial dysfunctions 
syndrome 1 (MMDS1) has been shown to arise from point mutations in NFU1, an essential 
iron-sulfur (Fe/S) protein implicated in multiple metabolic pathways and in energy 
production through Fe/S cluster delivery and trafficking [15,32,38,46,63,103,107]. A 
number of recent studies have offered insight into the natural cellular roles of this protein 
by investigating the downstream Fe/S proteins affected by substitution of one disease-




reduced function of target Fe/S proteins lipoic acid synthetase (LIAS) and succinate 
dehydrogenase (SDH) in the MMDS1 disease state suggests pathways that require proper 
function of the native NFU1 protein for cluster delivery [15,96]. However, the precise 
function of NFU1 in humans remains unknown. 
Analysis of the G208C NFU1 construct by our laboratory revealed an altered 
monomer-dimer equilibrium in vitro, which prevented reconstitution from physiologically-
relevant sources, suggesting the molecular basis for MMDS1 is the inability of NFU1 to 
accept cluster in vivo [108]. Recently, a heterozygous Gly189Arg substitution also on 
NFU1 has been shown to impact metabolic pathways related to the G208C substitution, 
despite lying farther from the cluster binding site (Fig. 1) [47,109]. In previously 
documented MMDS1 patient cases, the G208C mutation was either homozygous or 
heterozygous in conjunction with a deleterious frame-shift mutation, but heterozygous 
mutation alone was insufficient to display the disease phenotype, as the parents and siblings 
of the patients showed no symptoms [32,38]. However, in contrast to the G208C mutation, 
the G189R mutation has been reported as heterozygous, though present with either a 
G208C or frame-shift mutation [47,109]. Interestingly, patients with this mutation 
experience milder symptoms and a later age of onset when compared with those with the 
G208C mutation, suggesting a similar yet less severe impairment of function. In order to 
understand the molecular basis for the milder MMDS1 phenotype of the G189R derivative, 
we have undertaken a close examination of the effects of amino acid substitution at position 
189 on the structure and function of NFU1 in comparison to the previously documented 





3.2 Materials and Methods 
3.2.1 Protein preparation protocols 
 Stratagene QuikChange Mutagenesis was employed to introduce the p.Gly189Arg, 
p.Gly189Ala, and p.Gly189Lys point mutations in to the full length human NFU1 gene in 
the pET28b(+) plasmid [Primers in SI] [108]. Mutant and wild-type constructs in BL21 
DE3 cells were over-expressed in E. coli, and the proteins were purified using a TALON 
column as previously described [28]. A construct of human Grx2 (comprising residues 56-
161), with a tobacco etch virus cleavable N-terminal His6 tag in expression vector pNic-
Bsa4, was kindly provided by Drs. Kavanagh, Muller-Knapp and Oppermann and protein 
was expressed and purified as previously reported [69]. Schizosaccharomyces pombe Isa1 
protein was expressed and purified as previously reported [70]. Yeast Grx3 (Δ1–35) in 
pET28b(+) E. coli BL21 (DE3) was purified as noted [26].Purification of Hs IscU and 
Thermatoga maritima (Tm) Nifs was performed as previously reported [64-66]. Purified 
NFU1 constructs were reconstituted anaerobically with FeCl3 and L-cys as previously 
described, as were reconstitutions for Isa1 and ISU with FeCl3 and Na2S [28,108].  
Successful reconstitutions were confirmed by UV, CD and iron quantitation [81,110]. 
The expression vector for human ferredoxin-1 (Hs Fdx1) was kindly provided by 
J. Markley and protein was expressed and purified according to literature procedures [67]. 
Purification for human ferredoxin-2 (Hs Fdx2) was performed as previously reported [68]. 






3.2.2 Thermodynamic analyses and oligomeric state determination 
Differential scanning calorimetry (DSC) was performed using a MicroCal VP-DSC 
(Malvern Instruments, Inc.) on 200 μM samples using a differential mode of 0.1 ˚C per 
minute from 10 ˚C to 100 ˚C, and analyzed using Origin software (Origin Labs) [49,108]. 
For variable temperature circular dichroism (VTCD), 10 μM protein samples were dialyzed 
into 40 mM phosphate buffer, pH 7.4 for acquisition via a JASCO J-815 CD spectrometer 
with 0.1 cm quartz cells. Variable temperature studies were performed at a rate of 0.4 ° C 
min-1 from 20 to 95 °C monitoring signal at 222 nm, and data processed with Origin 7 
(Origin Laboratories) [49,108]. Secondary structure prediction of 10 μM samples in 
phosphate buffer (40 mM, pH 7.4) were obtained using CD by scanning from 300 – 165 
nm. The resulting CD spectra were processed using the analysis program CDSSTR [73] 
using reference set 7 [74] found on the online server Dichroweb [75,76].  Analytical 
ultracentrifugation (AUC) was employed to determine the oligomeric state of the NFU1 
constructs. Apo proteins at 50 μM were monitored at 280 nm in the presence and absence 
of 1 mM TCEP, and the sedimentation profiles were fit to the Lamm equation using 
SEDFIT [79,111].  
 
3.2.3 Kinetic analysis for second-order rate constant determination 
Kinetic cluster transfer experiments using CD were based on the cluster transfer 
experiments  by Johnson and coworkers [83,84], and refined by our own group [26,28]. 




a 1 cm anaerobic quartz cuvette by scanning from 600 – 300 nm at 200 nm/min at 25 °C 
after of the degassed holo protein or degassed glutathione-complexed [2Fe-2S] cluster 
([2Fe-2S](GS)4) complex. CD data were converted to the percentage of cluster transferred 
based on the concentration of [2Fe-2S] cluster and fit using DynaFit [89] to determine the 
second-order rate constants by best-fit simulation to second-order kinetics [27,90]. 
  Cluster extraction from holo NFU1 constructs was conduction on UV-Visible 
spectrophotometry by scanning from 800 - 200 nm at 600 nm/min at 25°C after the 
addition of holo protein. Glutathione concentrations were varied from 0.2 – 2 mM, and 
the reaction course monitored via the change in absorbance at 420 nm. The kobs was 
plotted against GSH concentration and fit linearly to obtain the second-order rate constant 
[26,28].   
 
3.3 Results and Discussion  
In this work, we have extended our analysis to a second disease causing mutation 
of NFU1. Patients have been found with a genetic point mutation that converts a glycine at 
position 189 of the amino acid sequence to an arginine (G189R), and when heterozygous 
with the previously discussed p.G208C substitution mutation or a c.146delC null mutation, 
also results in the disease condition known as MMDS1, although generally with milder 
symptoms in comparison to the homozygous G208C [46,109]. Although the 189 position 
is farther in sequence from the cluster-binding CXXC motif, the solution NMR of the C-
terminal domain (PDB ID: 2M5O) overlay with the Swiss Model homology model of the 




Furthermore, the G189R mutation introduces a significantly larger and positively charged 
side chain in the place of a flexible, small aliphatic one that could potentially affect the 
secondary Fe/S coordination sphere and thus Fe/S cluster transfer behavior, in addition to 
a disruption of global protein structure. Given that the heterozygous G189R/G208C disease 
phenotype is less severe than the homozygous G208C, yet still disease causing, whereas 
G208C and null mutation carriers remain unaffected, we sought to understand the 
molecular basis of disease of the G189R NFU1 mutation, particularly how this construct 
can disrupt protein structure or function by introducing 3 different amino acid substitutions 
at this position: G189R, G189K, and G189A.  
Initially, secondary structure and stability were examined via variable temperature 
CD (VTCD) by comparison of the melting profiles and thermodynamic characteristics with 
the native human NFU1 and the G208C mutant. All of the 189 constructs were fit to a two-
state model (equation 4), clearly reflecting the multi-domain nature of the protein (Fig. 2, 
Table 1) [49]. Interestingly, Tm1 and ∆H1 values, corresponding to the unfolding of the C-
terminal domain, are significantly lower in the 189 constructs than the native construct, 
whereas Tm2, corresponding to the unfolding of the N-terminal domain, is elevated in the 
189 constructs relative to the native, potentially pointing to a destabilizing effect of the 189 
mutation in the C-terminal domain that is compensated by increased ordering in the N-
terminal domain.  Both proteins exhibited reversible melting on VTCD (data not shown), 
indicating that the overall protein folds are relatively stable.  
CD was also used to examine the overall characteristics of protein secondary 




and random coil. The values are summarized in Table 2 and demonstrate an overall increase 
in random coil with a corresponding loss of secondary structural elements, most noticeably 
in the G189A construct. However, the modest change in secondary structural elements 
likely does not explain the changes in protein stability seen in the VTCD results, as the 
changes in either Tm or ∆H values do not correlate to changes in the relative abundance of 
random coil.  
Additional thermodynamic and structural characterization of G189X NFU1 using 
differential scanning calorimetry (DSC) reveals significant destabilization of the C-
terminal domain as reflected in Tm1 and ∆Hv1 values and broadening of the peak 
corresponding to the C-terminal domain unfolding (Figs. 3, S2; Tables 3, 4). N-terminal 
domain melting temperatures (Tm3) are comparable to the native, although enthalpies of 
unfolding (∆Hv3) are lower for the G189X derivatives, indicating the substitution mutations 
have a global destabilizing effect.   
As previously documented for the case of the G208C substitution, mutation at 
position 189 also strongly influences monomer-dimer equilibrium. Examination by 
analytical ultracentrifugation revealed that the 189 constructs strongly prefer monomer, as 
opposed to the relatively equal monomer to dimer ratio observed in the native, and the 
substantially increased the amount of dimer relative to the native in the G208C mutant 
(Figs. 4, S3). In addition to the destabilizing effect of mutation, the dramatic decrease in 
the relative abundance of dimer also likely contributes to the decreased melting 




been proposed that a dimer unfolding event occurs alongside the unfolding of the C-
terminal domain [108].  
Although mutation introduces small changes in thermodynamic parameters relative 
to the native and causes a primarily monomeric apo state, no significant changes in global 
stability were observed, so we sought to evaluate any differences in function relative to the 
native construct. Like the native and G208C constructs, the G189 derivatives were capable 
of undergoing reconstitution in vitro through the use of FeCl3 and L-cysteine with Tm NifS 
as a sulfide source. Following reconstitution, both UV and CD spectra look analogous to 
those reported for the native and G208C form, indicating the presence of a similarly bound 
[2Fe-2S] cluster. The cluster-bound 189 constructs also form as a dimer around the Fe-S 
cluster, as confirmed by AUC with monitoring at 420 nm (data not shown), with similar 
reconstitution yields to those observed for the native and G208C forms. 
The 189 constructs are also capable of conducting cluster uptake and transfer. 
Similar to the G208C construct, yet despite being largely monomeric, none of the 189 
derivatives were able to accept cluster from the [2Fe-2S](GS)4 complex, though this has 
been shown to be a viable substrate for reconstitution for proteins like NFU1 and export 
by the ABCB7 transporter [26,28,31,108,112]. Likewise, the 189 derivatives were unable 
to receive a Fe/S cluster from the donor protein Isa1, a proposed Fe/S cluster scaffold 
protein, indicating that one putative in vivo reconstitution pathway could be interrupted in 
the G189R NFU1 MMDS1 disease state. However, in contrast to the G208C derivative, all 
189 derivatives were able to accept cluster from human IscU, with transfer to G189R 




± 1400 M-1 min-1, though the G189A and G189K constructs demonstrated slightly slower 
uptake (Figure 5, Table 4). In the heterozygous G189R/G208C MMDS1 disease state, 
reconstitution of NFU1 in vivo is likely being impaired due to the inability of both NFU1 
mutants to receive an Fe-S cluster from the IscA1/2 assembly complex, yet not completely 
halted due to the apparently functioning IscU pathway for the G189R protein. The 
partially-functioning Fe/S trafficking pathway could explain the milder phenotype 
experienced by patients with the G189R mutation. 
Our previous work with the native and G208C forms of NFU1 has shown that a 
[2Fe-2S](GS)4 complex could be formed by Fe-S cluster extraction from the [2Fe-2S] 
cluster-bound native NFU1 under conditions of excess GSH, with a second-order rate 
constant of 130 ± 22 M-1 min-1 for the native and  140 ± 20 M-1 min-1 for the G208C mutant 
[28,108]. Excess GSH is also able to extract the [2Fe-2S] cluster from the 189 NFU1 
derivatives, and the decrease in absorbance was not due to cluster breakdown on the NFU1 
constructs, since a control in the absence of excess GSH demonstrated very little change in 
absorbance. Second-order rate constants for GSH extraction were determined as 1850 ± 30 
M-1 min-1 for the G189R derivative and 1200 ± 70 M-1 min-1 for the G189K derivative, 
which corresponds to a tenfold increase over that for the native and G208C constructs 
(Table 4). The extraction rate constant for G189A though elevated, was still on the same 
order of magnitude of the native construct. The dramatic increase observed for the G189R 
and G189K mutants suggests that the structural change and subsequent charge or steric 
effects which impact the monomer-dimer equilibrium and prevent efficient Fe/S cluster 




lability and impairing its ability to effectively transfer cluster for in vivo reconstitution of 
downstream target proteins for final delivery to proteins like LIAS and SDH.  
Once reconstituted, the G189X NFU1 derivatives are also capable of transferring 
the [2Fe-2S] cluster to apo protein targets. As found for native and G208C human NFU1, 
cluster transfer to ferredoxins (Fdx) 1 and 2 (Fdx1 and Fdx2) [28] and glutaredoxins (Grx) 
2 and 3 (Grx2 and Grx3) was observed [27], as monitored by the use of CD spectroscopy 
as previously reported [26,28,54,89,91,113]. Reconstituted holo G189X NFU was added 
to apo human Fdx1, and the increase in CD signal at 445 nm was monitored (Fig. 6 A and 
B) and used to yield a second-order rate constant for the transfer of [2Fe-2S] cluster of 
12,500 ± 1000 M-1 min-1 for G189R, about three-fold increase from the native, whereas the 
other two mutants demonstrated transfer rates similar to the native (Table 4). Cluster 
transfer from holo G189X NFU1 to human Fdx2 was monitored in a similar fashion and 
yielded an overall second-order rate constant in the range of that observed for the native. 
Cluster transfer kinetics for transfer to Grx was executed in the same manner, though since 
the Grxs utilize GSH as endogenous ligands, an excess of GSH was included in the 
reactions. Rapid transfer to the Grxs was observed for both Grx2 and Grx3 such that by the 
end of 2 min, the spectra already resembled those of the target holo proteins. For that 
reason, cluster transfer kinetics were monitored over 10-s intervals, instead of 2-min 
intervals. Transfer to apo human Grx2 resulted in a second-order rate constant of 2700 ± 
770 M-1 min-1 for G189R, and similarly lower values observed for the other constructs 
(Table 4).  Cluster transfer from holo G208C NFU1 to apo Saccharomyces cerevisiae Grx3 




8000 M-1 min-1 for G189R, essentially unchanged from the native (Table 4). Because the 
G189R NFU1 and the other mutant derivatives were capable of delivering a [2Fe-2S] 
cluster to the same target proteins that have been examined for kinetic transfer from the 
native form with second-order rate constants in close agreement with those observed for 
the wild-type, the disease phenotype is likely arises from an inability to effectively receive, 
hold on to a cluster under physiological GSH levels, and traffic an Fe/S cluster to 
downstream targets, rather than a disruption in the downstream transfer kinetic pathway.  
Our investigation into the G189R NFU1 mutation, as well as two other substitutions 
at position 189 has elucidated key facts regarding the structural and functional changes of 
NFU1 in the presence of the G189R substitution, and the how these alterations could 
contribute to the MMDS1 phenotype. Although mutation does not greatly affect 
thermodynamic parameters like ∆H and Tm, there is a small structural change which 
significantly impacts the monomer-dimer equilibrium. As a result, mutant NFU1 has an 
impaired although not eliminated ability to receive cluster from physiologically-relevant 
sources and increased Fe/S cluster lability when present in near cellular concentrations of 
GSH. The relatively unaffected cluster transfer kinetics from NFU1 also suggest a problem 
with Fe/S cluster reconstitution or stability in vivo as opposed to an inability to transfer the 
cluster to downstream targets once bound, since transfer rates were similar to the native 
protein. Nevertheless, it remains unclear how NFU1 interacts with other potential target 
proteins in the MMDS1 disease state, such as LIAS and SDH, and the connection between 









3.4 Figures and Tables 
 
Figure 3-1 Alignment of the human C-terminal domain of the NFU1 protein 
 (PDB ID: 2M5O; green trace), with corresponding cysteines in yellow. The Swiss-Model 
homology modeled structure generated for G189R NFU1 is shown in cyan with the 
arginine colored red. Numbering correlates with the full-length protein sequence.  
 
Figure 3-2 VTCD trace for the melting of 10 μM G189R human NFU1  
in 40 mM phosphate, pH 7.4. Data were fit to a two-state model (equation 4) to obtain Tm 
and ΔHV, which are shown in Table 1. CD units of ellipticity (mdeg) were used directly 
without conversion to molar ellipticity because the van’t Hoff enthalpies are independent 





Figure 3-3 Differential scanning calorimetry profiles for 0.2 mM G189R human NFU1 
 
The protein was in 50 mM HEPES, 100 mM NaCl, and pH 7.4. The data were fit using 
Origin 7.0 to obtain Tm and ΔHV values, all of which are listed in Tables 3 and 4. 
 
 
Figure 3-4 AUC profile for apo G189R NFU1 





















Apo protein was sedimented in the absence of TCEP (black) and in the presence of 1 mM 
TCEP (red). Sedimentation was monitored at 280 nm. The first peak of the black trace at 
24.6 kDa accounts for 95% of the sample, the second peak at 56.8 kDa accounts for 4%. 
The first peak of the red trace at 24.1 kDa accounts for 94% of the sample, the second peak 
at 60.6 kDa accounts for 4%. The AUC results were fit to the Lamm equation [79,111] 
using a continuous distribution model to obtain the peaks and molecular weights shown 
above.  
 
Figure 3-5 Kinetics of [2Fe-2S] cluster transfer from holo reconstituted human IscU to 
human G189R NFU1. 
 (A) Time course for cluster transfer to human G189R NFU1 monitored by CD in 50 mM 
Hepes and 100 mM NaCl (pH 7.5). Spectra were recorded every 2 min after the addition 
of holo IscU and were converted to (B) percent cluster transfer to yield an apparent second-
order rate constant from DynaFit of 5700 ± 1400 M−1 min−1 based on the concentration of 





Figure 3-6 A representative [2Fe-2S] cluster transfer from holo reconstituted human 
G189R NFU1 to apo human ferredoxin 1 (Fdx1).  
(A) Time course for cluster transfer to Fdx1 monitored by CD in 50 mM Hepes and 100 
mM NaCl (pH 7.5). Spectra were recorded every 2 min after the addition of holo G189R 
NFU1 and were converted to (B) percent cluster transfer to yield an apparent second-order 
rate constant from DynaFit of 12,500 ± 1000 M−1 min−1 based on the concentration of the 
[2Fe-2S] cluster [89]. 
 
 
 Tm1 (˚C) ∆Hv1 (kcal/mol) Tm2 (˚C) ∆Hv2 (kcal/mol) 
Native NFU1  55 ± 3 33 ± 2 74 ± 2 36 ± 3 
189R NFU1 38 ± 1 16 ± 1 79 ± 2 34 ± 4 
189A NFU1 40 ± 3 21 ± 1 80 ± 3 32 ± 1 
189K NFU1 42 ± 4 24 ± 4 77 ± 2 40 ± 1 
Table 3-1 VTCD data  
Native NFU1 and G189X NFU1 at 10 μM were subjected to melting from 20 to 95 °C at 







 α-helix β-sheet Random Coil 
Native NFU1 47 % 21 % 33 % 
189R NFU1 37 % 19 % 44 % 
189A NFU1 23 % 20 % 57 % 
189K NFU1 40 % 17 % 44 % 
Table 3-2 Percentages of secondary structural elements  
measured by CD and analyzed using the analysis program CDSSTR [73] on the online 
Dichroweb server [75,76]. 
 Tm1 (°C) Tm2 (°C) Tm3 (°C) 
Native  NFU1 60 ± 1 -- 73 ± 1 
G208C NFU1 49 ± 6 64 ± 2 74 ± 4 
G189R NFU1 52 ± 5 -- 75 ± 1 
G189A NFU1 53 ± 3 -- 77 ± 1 
G189K NFU1 49 ± 2 -- 80 ± 4 
Table 3-3 Melting temperatures as determined from fits to the DSC data 
The DSC profiles used for fitting are shown in Figure 3 and Figure S2. Native and 
G208C data were previously reported [108].  
 
 
 ΔHv1 (kcal/mol) ΔHv2 (kcal/mol) ΔHv3 (kcal/mol) 
Native NFU1 41 ± 2 -- 74 ± 5 
G208C NFU1 33 ± 4 50 ± 2 74 ± 4 
G189R NFU1 24 ± 1 -- 65 ± 20 
G189A NFU1 29 ± 2 -- 55 ± 3 
G189K NFU1 28 ± 6 -- 44 ± 6 
Table 3-4 Enthalpies of melting determined by DSC.  
The DSC profiles used for data fitting are shown in Figure 3 and Figure S2.  Native and 








 Native G208C G189R G189A G189K 
Human NFU1 to 
human Fdx1 
4700 ± 800 2600 ± 300 12500 ± 1000 3300 ± 750 2500 ± 930 
Human NFU1 to 
human Fdx2 
3900 ± 1200 1200 ± 200 3100 ± 250 3400 ± 200 21000 ± 2900 
Human NFU1 to 
human Grx2 
3740 ± 77 22400 ± 5000 2700 ± 770 1500 ± 500 2100 ± 300 
Human NFU1 to 
S. cerevisiae Grx3 
36200 ± 7700 14500 ± 3500 39500 ± 8000 29000 ± 3700 6700 ± 1900 
Human IscU to 
Human NFU1 
4750 ± 8 No transfer 5000 ± 1200 3200 ± 30 3000 ± 110 
S. pombe Isa to 
human NFU1 
6700 ± 1560 No transfer No transfer 1750 ± 110 No transfer 
[2Fe-2S](GS)4 
to human NFU1 
1930 ± 210 No transfer No transfer No transfer No transfer 
Human NFU1 to 
[2Fe-2S](GS)4 
130 ± 22 140 ± 20 1800 ± 30 360 ± 70 1200 ± 70 
Table 3-5 Second-order rate constants for [2Fe-2S] cluster transfer to and from NFU1.  
 Native transfer rates were previously determined using the same CD method 







Chapter 4 : Analysis of NFU-1 Metallocofactor Binding Site Mutations: Impacts on Iron-
Sulfur Cluster Coordination and Protein Structure and Function  
 
4.1 Introduction 
Iron-sulfur (Fe/S) cluster assembly in vivo occurs via three organized Fe/S cluster 
biosynthetic pathways. The Isc (iron-sulfur cluster) system is the predominant pathway for 
cluster assembly in humans, with de novo [2Fe-2S] cluster biosynthesis on the scaffold 
protein IscU [96], which are then transferred to target proteins via a series of chaperones 
and delivery proteins. One such delivery protein, NFU1 can bind a [2Fe-2S] cluster [28] 
that is then transferred to other partner proteins. NFU1 is comprised of two domains; a 
structure-defining N-terminal domain, and a functional molten globular C-terminal domain 
that holds the cluster binding site at a highly-conserved CXXC motif [49,51,114]. The 
molten globular nature of the cluster binding domain is believed to provide the structural 
flexibility required for function in iron-sulfur cluster uptake and delivery [49,108].  
Recently, a point mutation in NFU1 (p.Gly208Cys) that lies in close proximity to 
the Fe/S cluster binding site has been implicated as the cause of the Multiple Mitochondrial 
Dysfunction Syndrome 1 (MMDS1) disease state [38]. This substitution alters the protein 
sequence surrounding the cluster binding motif, changing the native sequence from 
GXCXXC to CXCXXC [38], with a subsequent structural change that is intimately tied to 
its function [108]. Other consequences of this point mutation may arise because a potential 




inextricably linked to cluster geometry and coordination. Fe/S centers are generally ligated 
via cysteine residues in highly-conserved motifs [17], such as the CXXC sequence of 
native NFU1; however, non-cysteinal ligands such as histidine [18], serine [20], and a 
variety of other amino acids [19] have been observed. Furthermore, non-protein derived 
ligands have been shown to function as cluster ligands, such as a water molecule in the 
iron-sulfur cluster scaffold IscU [21] and S-Adenosylmethionine (SAM) in lipoic acid 
synthase [20]. The impact of cluster coordination extends beyond the primary coordination 
sphere by controlling protein structure around the cluster-binding site [12], which can 
effect changes in both overall protein structure and function. Properties such as reduction 
potential, can be specifically tuned based on the amino acids in the inner and outer cluster 
coordination sphere [12,115].  
For NFU1, the altered (CXCXXC) motif in the mutant protein resembles other 
cluster-binding sequences that have been previously identified. The same sequence occurs 
twice in a small T antigen from Merkel cell polyomavirus that is capable of binding a [2Fe-
2S] cluster at one site, and a [4Fe-4S] cluster with a fourth ligand of uncertain identity at 
another [116]. Similarly, a cytosolic Fe/S cluster assembly protein, anamorsin (Dre2 in 
yeast) utilizes a CXXCXC sequence to bind a [2Fe-2S] cluster that resembles the motif 
found in the NFU1 disease state [117]. These two proteins exhibit very different cellular 
roles, demonstrating the importance of the Fe/S cluster coordination state on overall protein 
structure and function, and the role of perturbations to the cluster binding motif to alter 




cluster-binding motif has on NFU1 structure-function characteristics, and how this change 
contributes to the MMDS1 disease state.  
In this paper, we have selectively mutated the glycine at position 208 and the 
cysteine residues at positions 210 and 213 to alter the cluster binding motif. By analysis of 
these complementary mutations we conclude that the introduction of a third cysteine does 
not increase the number of cysteine ligands to the iron-sulfur cluster, and that modulation 
of ligating residues does not cause a significant change in structure. Rather, mutation at 
position 208 dominates subsequent coordination to the cluster, forcing a change in cysteine 
ligation that results in the structural and functional effects observed in vitro. These results 
clarify how the G208C mutation inhibits cluster uptake by NFU1, most likely giving rise 
to the MMDS1 disease state.  
 
4.2 Materials and Methods 
4.2.1 Mutagenesis 
Strategene QuikChange Mutagenesis was employed to introduce a series of point 
mutations in full length human NFU1. The PCR reaction contained 50 ng of native NFU1 
DNA in pET28b(+) plasmid, 2 units of Phusion DNA polymerase (New England Biolabs), 
10x Phusion buffer (New England Biolabs), 125 ng of each primer (Integrated DNA 
Technologies), 0.2 mM dNTPs, and 3% DMSO. The native plasmid was utilized to 
generate two single mutant variants: p.Gly208Ala and p.Gly208Ser (primers in Table S1). 
The p.Gly208Cys mutant plasmid was generated as previously described [108]. In all cases, 




melted by heating to 95 ˚C for 1 min, followed by 16 cycles of 95 ˚C for 30 sec, 55 ˚C for 
1 min and 72 ̊ C for 6.5 min (Stratagene).  Following amplification, samples were incubated 
with 7.5 units of DpnI at 37 ˚C for 4 h, and CaCl2-competent BL21 (DE3) cells 
subsequently transformed via heat shock with the mutant constructs.  Mutagenesis results 
were confirmed by nucleotide sequencing from GENEWIZ.  The p.Gly208Cys DNA was 
then used to introduce the second point mutation at either the 210 or 213 positions 
following the protocol outlined above (primers in Table S1).  
 
4.2.2 Protein expression and purification 
All of the NFU1 constructs in a pET28(b+) vector in E. coli strain BL21(DE3) host 
cells were grown overnight at 37 °C in 10 mL of Luria–Bertani (LB) broth media 
containing kanamycin (50 μM) [50]. The overnight cultures were diluted 1:1000 in LB 
media containing 50 μM kanamycin until the OD600 reached 0.6. At this point, protein 
expression was induced with 0.5 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG), 
and cultures were incubated overnight at 37 °C. Cell pellets were collected by 
centrifugation at 4,330g for 15 min at 4 °C, and resuspended in 30 mL of 50 mM HEPES, 
100 mM NaCl, pH 7.5. Resuspended pellets were incubated with 30 mg lysozyme and 0.6 
mg DNase I for 30 min at 4 °C, and then lysed by use of a dismembranator. Cell lysate was 
centrifuged at 28,982g for 50 min at 4 °C, and the supernatant applied to a TALON column. 
Protein was eluted with a buffer containing 50 mM HEPES, 100 mM NaCl, 150 mM 




Purification of Hs ISU and Thermatoga maritima (Tm) Nifs was performed as 
previously reported [64-66]. The expression vector for human ferredoxin-1 (Hs Fdx1) was 
kindly provided by J. Markley and protein was expressed and purified according to 
literature procedures [67]. Purification of human ferredoxin-2 (Hs Fdx2) was performed as 
previously reported [68]. Briefly, Hs Fdx1 was purified by use of DE-52 anion exchange 
column chromatography followed by FPLC purification with a size exclusion Superose-12 
column (HR 16/50, Pharmacia) run at 0.2 mL/min with 50 mM HEPES, 100 mM NaCl, 
pH 7.5 at 40 C. All of the colored fractions were collected and combined.  Purification for 
human ferredoxin-2 (Hs Fdx2) was performed by use of a TALON column as previously 
reported [68]. Protein was eluted with a buffer containing 50 mM HEPES, 100 mM NaCl, 
150 mM imidazole, pH 7.5 and concentrated by amicon ultrafiltration over a 10 kDa 
membrane. The ferredoxins purified as holo proteins and were subsequently converted to 
the apo form by treatment with 100 mM EDTA, 5mM DTT and 8M urea in a solution of 
50 mM HEPES, 100 mM NaCl, pH 7.5. A construct of human Grx2 (comprising residues 
56-161), with a tobacco etch virus cleavable N-terminal His6 tag in expression vector pNic-
Bsa4, was kindly provided by Drs. Kavanagh, Muller-Knapp and Oppermann and protein 
was expressed and purified as previously reported [69]. Schizosaccharomyces pombe Isa1 
protein was expressed and purified as previously reported [70]. Yeast Grx3 (Δ1–35) in 
pET28b(+) E. coli BL21 (DE3) was purified as described [26]. 
In all cases, protein purity was assayed by use of 12 % SDS-PAGE that was 
visualized with Coomassie Blue staining. Imidazole was removed by dialysis at 4 °C 




concentration was determined by the Bradford assay and confirmed by absorbance 
measurements by use of the protein’s extinction coefficient at 280 nm.  
 
4.2.3 Differential scanning calorimetry  
DSC samples (0.15 mM – 0.2 mM) were dialyzed against 50 mM HEPES, 100 mM 
NaCl, pH 7.5 at 4 ˚C with Spectra/Por dialysis membrane (MWCO 10 000; Spectrum 
Laboratories, Inc.).  The resulting dialysis buffers were used as reference cell buffers for 
precision and repeatability.  Reference buffers and protein samples were thoroughly 
degassed using a MicroCal Thermovac2 (Malvern Instruments, Inc.) prior to analysis on a 
MicroCal VP-DSC (Malvern Instruments, Inc.).  The data were obtained using a 
differential mode at a rate of 1.0 ̊ C per minute from 10 ̊ C to 100 ̊ C, analyzed using Origin 
software (Origin Labs), and fit to a non-two state DSC curve fitting model to account for 
the multiple protein domains [49].  
 
4.2.4 Variable temperature circular dichroism characterization 
Circular dichroism (CD) samples (10 μM) were dialyzed in phosphate buffer (40 
mM phosphate, pH 7.4) with Spectra/Por dialysis membrane (MWCO 10,000; Spectrum 
Laboratories, Inc.). The resulting dialysis buffers were used as reference cell solvents for 
precision and reproducibility. Prior to analyses, all sample and reference solutions were 
rigorously degassed with a Microcal Thermovac2 device (Malvern Instruments, Inc.). All 
CD data acquisitions were obtained on a JASCO J-815 CD spectrometer (JASCO) 




performed at a rate of 0.4 ° C min-1 from 20 to 95 °C, and all data were processed with 
Origin 7 (Origin Laboratories). VTCD data were fit to equation (1) for Tm and ΔHV 
determination for a one-state melting model indicative of a one-phase transition [49], where 
R is the ideal gas constant in calories per mole, Tm is the melting temperature in Kelvin, 
ΔHV is the van’t Hoff enthalpy, and Cp is the heat capacity. F and U represent the mean 
residue ellipticities (θmr) of the folded and unfolded protein, respectively. Data were fit to 
a one-state model to examine the possibility of a concerted secondary structure melting 
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4.2.5 Secondary structure prediction from circular dichroism 
 Protein samples at 10 µM in 40 mM phosphate, pH 7.4 were placed in a 1 mm 
quartz cuvette and the signal monitored from 300 – 165 nm. The baseline signal from the 
buffer was subtracted before converting the data  to ∆ε. The resulting CD spectra were 
processed using the analysis program CDSSTR [73] using reference set 7 [74] found on 
the online server Dichroweb [75,76].  
 




NifS-mediated in vitro reconstitution of G208C NFU1 was completed as previously 
described [28,77]. Briefly, ferric chloride and L-cysteine were added to an anaerobic 
mixture of approximately 200 μM purified NFU1, 2 μM T. maritima (Tm) NifS, and 5 mM 
DTT to final concentrations of 1.6 mM FeCl3 and 3.2 mM L-cysteine. Alternatively, 
sodium sulfide and ferric chloride were added to an anaerobic mixture of approximately 
200 μM purified NFU1, 2.1 mM urea, and 5 mM DTT to final concentrations of 1 mM 
FeCl3 and 1 mM Na2S [26]. The final solution was incubated for 1 h with stirring at room 
temperature, before separation of excess urea, iron and sulfide through a PD-10 column 
that was equilibrated with an argon-purged solution of 50 mM HEPES, 100 mM NaCl, pH 
7.5. Reconstituted protein was eluted with 3.5 mL of the equilibration buffer and 
concentration determined by both the Bradford assay and by absorbance at 330 nm and 420 
nm on a Cary WinUV spectrophotometer. 
For ISU and Isa1 [78], 200 μM apo protein was incubated with 50 mM DTT, argon-
purged for 30 min, and then made up to 1 mM in Fe2+ and 1 mM in S2-. After incubation 
for 1 h, the reaction mixture was concentrated and passed through a PD10 desalting column 
to remove excess DTT, Fe2+ and S2-, and the UV-vis spectrum was obtained for each of 
apo and holo ISU and Isa1. 
 
4.2.7 Reconstitution analysis by circular dichroism 
CD scans of apo and holo proteins were recorded on a JASCO J-815 CD 
spectrometer in a quartz 1 cm anaerobic cuvette. CD scans from 300 nm to 600 nm were 




25 °C. Data were processed using JASCO Spectramanager II Analysis software and were 
represented in Origin 7.0.  
 
4.2.8 Oligomerization state determination by analytical ultracentrifugation  
The four NFU1 double mutant variants at 50 μM protein concentration (OD280 = 
1.0), in the presence or absence of 1 mM TCEP, were loaded into the ultracentrifugation 
chambers and sealed. Buffer samples containing 50 mM HEPES, 100 mM NaCl, pH 7.5 
were used as a reference, with the addition of 1 mM TCEP where needed. Reconstituted 
holo NFU1 mutant variants at an OD420 = 1.5 were loaded in the same manner with the 
same reference buffer. Samples were centrifuged at 45,000 rpm for 6 h to reach complete 
sedimentation, and the sedimentation profiles were fit using SEDFIT to the Lamm equation 
[79,80]. 
 
4.2.9 [Fe2S2](GS)4] Synthesis 
The cluster used was synthesized as previously reported [30]. Briefly, ferric 
chloride (20 mM) and sodium sulfide (20 mM) were added to 10 mL 40 mM glutathione 
solution, pH 8.6. A volume (40 mL) of ethanol was added to the mixture and mixed by 
vortexing. The precipitate was collected by centrifugation at 13,000 rpm for 10 min, 
washed twice with ethanol and dried under vacuum. 
 




 A solution of [Fe2S2](GS)4 (0.05 mM, 200 μL) in H2O or holo protein was acidified by 
concentrated HCl (60 μL) and heated to 100 ºC for 15 min. The resulting suspension was 
centrifuged at 14,000 rpm for 2 min and the supernatant (100 μL) was diluted with Tris-
HCl (0.5 M, 1.3 mL, pH 8.5). Solutions of sodium ascorbate (0.1 mL, 5%) and 
bathophenanthroline-disulfonate (0.4 mL, 0.1%) were sequentially added to the neutralized 
reaction solution with mixing between each addition. The solution was incubated at 25 ºC 
for 1 h and iron was quantitated by measuring the absorbance at 535 nm on a UV-vis 
spectrophotometer and calculated from a calibration curve made with 0.01-0.2 mM FeCl3 
standard solutions (Fig. S1) [78,81]. 
 
4.2.11 Iron-sulfur cluster uptake monitored by CD  
The ability of the NFU1 double mutants to take up an iron-sulfur cluster from the 
[2Fe-2S](GS)4 complex was examined by circular dichroism (CD). CD scans were 
recorded on a JASCO J-815 CD spectrometer in a 1 cm anaerobic quartz cuvette from 600 
– 300 nm at a scan rate of 200 nm/min at 25°C, with a 2 min interval between each 
accumulation. The protein (50 μM) in 50 mM HEPES, 100 mM NaCl pH 7.5, was 
thoroughly degassed in the presence of 5 mM DTT and transferred to the anaerobic cuvette. 
Solid [2Fe-2S](GS)4 was resuspended in degassed 50 mM HEPES, 100 mM NaCl pH 7.5 
and added to the argon-purged anaerobic cuvette via a gas-tight syringe to a final 
concentration of 400 μM to initiate the reaction. Data were processed using JASCO 
Spectramanager II Analysis software and analyzed in Origin 7.0. The deconvolution 




spectra that contained overlapping Lorentzian curves having the same full width at half 
maximum value that accurately distinguishes the peak positions for each band. 
 
4.2.12 Kinetics of [2Fe-2S] cluster extraction by glutathione from holo NFU1  
Glutathione has been previously shown to extract the iron-sulfur cluster from 
various holo proteins to form the [2Fe-2S](GS)4 complex by monitoring the change in the 
charge-transfer bands at 330 nm and 420 nm by UV-Vis spectrophotometry [26,30]. As 
was done for native holo NFU1 [28], degassed, reconstituted holo double mutant NFU1 in 
50 mM HEPES, 100 mM NaCl, pH 7.5 was incubated with a 4- to 10-fold excess of GSH 
in an anaerobic cuvette and the absorbance at 420 nm on a Cary Win UV spectrophotometer 
was monitored every 2 min over the course of 1 h. The change in absorbance at 420 nm 
was plotted against time and fit to an exponential decay to obtain kobs. A control reaction 
for holo double mutants in the absence of excess GSH was carried out under the same 
conditions to account for inherent cluster instability. Cluster extraction by GSH to form the 
[2Fe-2S](GS)4 complex was confirmed using ESI mass spectrometry on a Bruker Micro-
TOF (ESI) spectrometer and data was analyzed by use of Bruker DataAnalysis software  
[30,82]. 
 
4.2.13 Kinetic cluster transfer experiments  
Kinetic cluster transfer experiments were designed based on the cluster transfer 
experiments by Johnson and coworkers [83,84], and refined by our own group [26,28]. 




quartz cuvette from 600 – 300 nm at a scan rate of 200 nm/min at 25°C, with a 2 min 
interval between each acquisition. Reactions that reached completion within the first 10 
min were analyzed over a 10 nm wavelength scale, based on the peak of interest, with 10 
second intervals between acquisitions. Spectra were processed using JASCO 
Spectramanager II Analysis software and were represented in Origin 7.0.  
Reactions in 50 mM HEPES, 100 mM NaCl, pH 7.5 were prepared by degassing a 
mixture of 40 μM apo protein in 5 mM DTT, and transferred to an anaerobic cuvette via a 
gas tight syringe. Degassed holo protein at 40 μM was added to the cuvette to initiate the 
reaction. The concentration of [2Fe-2S] in the reaction for each holo protein was 
determined via standard iron quantitation methods. 
Kinetics of cluster transfer was analyzed by converting the change in CD signal to 
the percentage of cluster transferred. The plot of time versus percent cluster transfer was 
fit using DynaFit [89] to obtain the second-order rate constant by a best fit simulation to 






 To more thoroughly understand the impact of the altered Fe/S cluster binding motif 
in the MMDS1 disease state, we have generated a series of point substitutions of NFU1 to 
investigate the occurrence of Cys ligation to the bound cluster (Table 1). Single mutant 
constructs were created where the glycine residue at position 208 was mutated either to 
alanine, a more rigid and slightly bulkier residue that is sterically similar to cysteine, or to 
serine, a ligand that is capable of binding a Fe/S cluster, though less favorably than cysteine 
[65,118]. These selections allow for the separation of effects on cluster binding that are 
observed in the G208C construct as a result of changes in size or ligation behavior relative 
to the identity of the residue at this position. Additionally, double mutant constructs were 
created where the 208 cysteine mutation was retained, while the cysteine residues at 
positions 210 and 213 were substituted with either alanine or serine in order to investigate 
differences in cluster-binding and transfer behavior as the typical CXXC motif was 
interrupted. Each of these six protein constructs was then purified and characterized with 
regard to structural and functional properties of their apo and holo protein states.  
 
4.3.1 Apo protein stability characterization of single mutant constructs 
Detailed secondary and tertiary protein characterization has already been reported 
for native human NFU1 [49] and the G208C mutant variant [108]. These results 
demonstrated that the mutant protein maintains less overall secondary structure in the 
monomeric form, which alters the monomer-dimer equilibrium to favor the dimer species. 




physiologically-relevant sources in vivo, likely giving rise to the MMDS1 phenotype [108]. 
To examine additional single mutations at the 208 position, secondary structure and 
stability were likewise examined via variable temperature circular dichroism (VTCD), and 
the melting profiles and thermodynamic characteristics contrasted to those obtained from 
the native human NFU1 and the G208C mutant (Figure 1; Figure S1). Data were fit to a 
one-state model (Table 2), indicative of a concerted unfolding mechanism of both the N- 
and C-terminal domains [119]. The native NFU1 and mutant constructs all show similar 
melting traces, with no significant deviations in the melting temperature and enthalpy of 
unfolding, within error, indicating relatively comparable secondary structural stability.  
Circular dichroism was also utilized to examine the overall characteristics of 
protein secondary structure by determining the percentages of secondary structural 
elements: α-helix, β-sheet and random coil. The values are summarized in Table 3. 
Substitutions at residue 208 were observed to increase the relative amount of random coil 
while decreasing α-helical content, but did not perturb overall secondary structure stability, 
based on the VTCD results (Figure 1; Table 2). The G208C construct maintains the closest 
semblance to the native, followed by G208S then G208A.  
 Differential scanning calorimetry (DSC), was also utilized to determine the 
thermodynamics and heat capacity of unfolding for all of the mutant variants, relative to 
the native protein (Tables 4 and 5). The DSC profile for the G208A and G208S variants 
did not show the additional third peak observed for G208C that was ascribed to dimer 
unfolding [108], but rather they resembled the two-state melting process of the native 




G208A construct, and Tm1 =  61 ± 3 °C and Tm2 = 75 ± 1 °C for the G208S construct. The 
lower Tm values correspond to the melting of the C-terminal domain and the higher melting 
temperatures represent melting of the well-folded N-terminal domain [49]. Although the 
mutant melting temperatures are similar to the native state, the mutant constructs show 
lower van’t Hoff enthalpies than the native, reflecting the higher percentage of random coil 
from secondary structure contributions.  
 Because the prominent third DSC peak observed in the G208C derivative was not 
observed for the G208A and G208S mutant variants, analytical ultracentrifugation (AUC) 
experiments were then performed to investigate whether the mutations had any effect on 
oligomerization trends as previously noted for the G208C construct. AUC was completed 
for both apo G208A and G208S NFU1 in the presence and absence of 1 mM TCEP to 
eliminate the potential for oligomerization due to disulfide bond formation. Both mutant 
constructs showed a strong preference for the monomer form (expected: 23.9 kDa) which 
contributed 70% of the species for G208A and 90% of the species for G208S (Figure 3; 
Table 6). Dimer for G208A and G208S accounted for 22% and 8% of the species, 
respectively. No higher order species were observed for G208S, although a peak at 102 
kDa as 2% of the species could reflect a small tendency of G208A towards tetramer 
formation, similar to prior observations for G208C [108]. Even in the presence of TCEP, 
these values remain essentially unchanged. This supports a crucial role for residue 208 in 
determining oligomerization trends independent of disulfide bonding or cofactor binding. 
The increased presence of dimer exhibited by the G208C mutation is thought to be the 




conclusion that is supported by the drastic changes in oligomeric ratios as the residue at 
position 208 is altered.  
 
4.3.2 Apo protein stability characterization of double mutant constructs 
 Stability characterization was conducted on the G208C/C210X (where X=S/A) and 
G208C/C213X (X=S/A) double mutant constructs in addition to the single mutant 
constructs. Data were again fit to a one-state model (Table 7), indicative of a concerted 
unfolding mechanism of both the N- and C-terminal domains. The native NFU1 and mutant 
constructs all show similar melting traces (Figure 4; Figure S2), though the double mutants 
generally have slightly higher melting temperatures and enthalpies of unfolding indicative 
of an energetically favorable change in secondary structure. Similar results were observed 
independent of the replacement residue or residue position.  
However, analysis of protein secondary structures using circular dichroism shows 
a dramatic dependence on the position of the mutation, with the 210 double mutants 
showing a substantial decrease in the amount of α-helix, complemented by an equal 
increase in the amount of random coil. The values are summarized in Table 8. It is 
interesting to note that this increase in random coil does not correlate with a decrease in 
stability as evidenced by the thermodynamic parameters obtained from VTCD, suggesting 
that the protein is adopting an equally stable conformer despite the lack of canonical 
ordered secondary structure.  
 Differential scanning calorimetry was again performed to investigate any tertiary 




identified alterations in secondary structure. Interestingly, although the G208C mutation 
was incorporated, none of the double mutant constructs displayed the three-phase melting 
trace observed for the G208C single mutant (Figure 5); rather, all four double mutant DSC 
traces resembled the native curve with a two-phase melting event indicative of the separate 
N- and C-terminal melting events already discussed, with dimer dissociation inseparable 
from those events [49]. The respective first melting events show little deviation from that 
of the native, with the notable exception of G208C/C213S, which occurs about 4 ˚C higher 
at Tm1 = 63 ± 1 ˚C (Table 9). The second melting event has slightly more variance, with a 
noticeable increase for G208C/C210A which occurs at Tm2 = 79 ± 1 ˚C and a noticeable 
decrease for G208C/C213A which occurs at Tm2 = 66 ± 2 ˚C. Alternatively, the serine 
double mutants maintain their similarity with the native construct, with their second 
melting events occurring at Tm2 = 74 ± 2 ˚C for the G208C/C210S construct and Tm2 = 72 
± 2 ˚C for the G208C/C213S construct (Table 9). Conversely, all double mutants display a 
noticeable decrease in their enthalpies of melting, indicating an overall destabilizing effect 
initiated by the mutations, which is not present at the secondary structure level (Table 10).  
Although minor changes to melting temperature and thermodynamic stability are 
present as a result of the point substitutions, the most dramatic effects were observed in 
AUC experiments to examine oligomerization behavior. As discussed previously, all 
samples were run in the presence and absence of 1 mM TCEP in order to separate 
oligomerization effects due to disulfide bonding from those due to electrostatic interaction. 
All double mutants displayed a substantially decreased preference for the monomer state 




constructs displayed an increased preference for higher-order oligomers with trimer species 
for C213A at 15.2 % and C213S forming a tetramer comprising 47% of the species (Figure 
6; Table 11); whereas no higher-order oligomers are observed for the native construct 
[108]. Higher-order oligomerization effects are less pronounced for the G208C/C210 
constructs, although there is still a decreased preference for monomer (Figure 6; Table 11). 
Due to the consistent increased preference of the double mutant constructs for higher-order 
oligomeric species, and the large variance observed for the G208 single mutant constructs, 
it is likely that the G208C mutation dominates this effect.  
 
4.3.3 Holo protein functional characterization of single mutant constructs  
 
 Following a thermodynamic and structural analysis of the two single mutants, in 
comparison to the native construct and the disease-causing G208C construct, the functional 
changes resulting from the mutation were next examined to understand how the differences 
in oligomeric state impacted Fe/S cluster binding and transfer behavior. Similar to the 
native and G208C constructs, the single mutants were readily reconstituted in vitro by use 
of FeCl3, L-cysteine and Tm NifS, and yielded UV spectra displaying typical iron-sulfur 
cluster charge-transfer bands at 330 and 420 nm (Fig. 9). Native NFU1 and the G208C 
construct have been shown to bind a [2Fe-2S] cluster under similar reconstitution 
conditions [28,108], while UV and CD spectra reveal no significant differences between 
samples, consistent with the G208A and G208S constructs also binding a [2Fe-2S] cluster 




ferredoxins. Based on iron quantitation, reconstitution yields of 0.84 [2Fe-2S]/dimer for 
G208A and 0.86 [2Fe-2S]/dimer for G208S were obtained, both similar to the yield 
achieved for previous NFU1 reconstitutions [28,108]. Protein oligomerization around the 
cluster was confirmed by use of AUC, with monitoring at 420 nm to follow the cluster-
bound form of the protein. Oligomeric species were the major constituents of G208A and 
G208S holo samples, with a preference for tetramer formation in the G208A sample and 
dimer formation in the G208S sample (data not shown).  
Our previous analysis of both the native human NFU1 and the G208C constructs 
showed that the native human protein was capable of receiving and transferring cluster 
from other Fe/S proteins [27,28,90]; whereas the G208C construct was incapable of 
receiving an Fe/S cluster from any physiologically-relevant source, but could transfer a 
cluster once reconstituted, though with perturbed kinetic preferences [108]. Native NFU1 
was also able to receive cluster from a physiologically-relevant glutathione-bound iron-
sulfur cluster complex [2Fe-2S](GS)4, but not the G208C construct [28,108]. This 
glutathione complex has been shown to be taken up by a number of apo iron-sulfur cluster 
proteins [26,30] and is a viable substrate for the mitochondrial ABCB7 transporter [29,82], 
suggesting a possible role for the [2Fe-2S](GS)4 complex as a component of the labile iron 
pool. Native human NFU1 can take up a [2Fe-2S] cluster from the complex with a second-
order rate constant of 1930 M-1min-1 [28], as observed by circular dichroism (CD) [28]. 
The G208A construct was also able to take up a [2Fe-2S] cluster moderately faster with a 
larger second-order rate constant of 3500 M-1min-1 (Figure 7). However, the G208S 




Conversely, only the G208S construct was able to receive cluster from two donor 
proteins S. pombe Isa1 and human IscU, in contrast to both the G208C and the G208A 
constructs. We have previously demonstrated that these [2Fe-2S] cluster scaffold proteins 
are able to transfer an iron-sulfur cluster to native human NFU1 [27,90]. Therefore, we 
have examined the ability of the single mutant proteins to be reconstituted in the same way 
by use of CD spectroscopy. Holo reconstituted human IscU was added to apo G208S  (Fig. 
8C) and the resulting spectral change was used to extract a second-order rate constant of 
2300 ± 90  M-1 min-1, slightly smaller than the value of 4750 ± 8 M-1 min-1 observed with 
the native protein. Likewise, S. pombe Isa1 was added to the apo single mutant targets and 
reacted for 1 h (Fig. 8A). The G208S construct could again receive cluster with a smaller 
second-order rate constant of 3200 ± 850 M-1min-1 compared to 6700 M-1min-1 for native 
NFU1 (Table 12). Because the transfer was rapid, it was also monitored at 360 nm at 10 
sec intervals to confirm the second-order rate constant (Fig. 8D).  
Our previous work with native and G208C forms of NFU1 has quantitatively 
addressed a role for NFU1 in Fe/S cluster delivery and trafficking. As such, the [2Fe-
2S](GS)4 complex could be formed by cluster extraction from both the [2Fe-2S] cluster-
bound native protein and G208C NFU1 under conditions of excess glutathione (GSH), 
with similar second-order rate constants of 130 ± 22 M-1min-1 and 142 ± 24 M-1min-1, 
respectively [28]. Excess GSH is also able to extract the [2Fe-2S] cluster from holo 
G208A and G208S NFU1, and the decrease in absorbance at 420 nm was monitored over 
the course of an hour (Fig. 9A). The decrease in absorbance was not due to cluster 




demonstrated very little change in absorbance (Fig 9B). The change in absorbance data 
was determined at six different concentrations of excess GSH and kobs plotted against 
GSH concentration (Fig. 9C), and the initial slope fit to a linear equation to determine the 
second-order rate constant for GSH extraction of the [2Fe-2S] cluster from G208A of 520 
± 80 M-1min-1 (Table 12). The plot was also fit to a saturation kinetics model to 
determine the K and k1 values (12); however, this was the only mutant construct to 
demonstrate this behavior. By contrast, the G208S construct displayed no dependence on 
the concentration of glutathione, and a rate constant of 205 ± 71 M-1min-1 was 
determined.  
 Both single mutants were also capable of transferring the [2Fe-2S] cluster to other 
apo protein targets. As found for the native and G208C human NFU1, cluster transfer to 
ferredoxins 1 and 2 (Fdx1 and Fdx2) and glutaredoxins 2 and 3 (Grx2 and Grx3) was 
observed [27,28,90,108]. Cluster transfer was monitored by use of CD spectroscopy, 
because unique spectra are generated for each iron-sulfur cluster bound protein, converted 
to percent cluster transfer and fit using DynaFit [89] to determine the second-order rate 
constants [91], which are summarized in Table 12. Reconstituted holo G208A or G208S 
were added to apo human Fdx1 and the increase in CD signal at 445 nm was monitored 
(Fig. 10) and used to yield second-order rate constants for transfer of [2Fe-2S] cluster of 
12000 ± 2800 M-1min-1 for G208A and 19000 ± 1700 M-1min-1 for G208S, both of which 
are significantly larger than the observed 4700 M-1min-1 for native NFU1. Similarly, cluster 
transfer from the single mutants to Fdx2 yielded an overall second-order rate constant of 




the observed 3800 M-1min-1 for the native protein. Transfer was monitored at 10 s intervals 
at 440 nm for both Fdx1 and Fdx2 to capture the rapid transfer reaction that was too fast to 
be observed with 2 min intervals.  
 Cluster transfer kinetics for transfer to glutaredoxins was conducted in the same 
manner as for the ferredoxins. The change in CD signal was monitored following addition 
of holo reconstituted single mutant NFU1 to either apo Grx2 or apo Grx3. Since the 
glutaredoxins utilize glutathione as endogenous ligands, an excess of GSH was included in 
these reactions to be able to reconstitute a functional glutaredoxin protein. Although excess 
GSH has been shown to extract the cluster from Fe-S proteins [26,28,30], transfer from 
NFU1 to the glutaredoxins was direct as no intermediate spectra were observed during the 
transfer which would represent formation of a transitory complex. Consistent with no 
intermediates of a [2Fe-2S](GS)4 complex [30], the observed rates were faster than those 
obtained for direct reconstitution using the [2Fe-2S](GS)4 complex. Transfer to Grx2 
yielded a slightly higher second-order rate constant of 6300 ± 380 M-1min-1 for G208A, 
while G208S was found to transfer with a slower rate constant of 1500 ± 97 M-1min-1, in 
comparison to the 3700 M-1min-1 observed for native. However, cluster transfer to Grx3 
occurred at much slower rates for both single mutant constructs in comparison to the native 
protein. Specifically, single mutant transfers to Grx3 yielded second-order rate constants 
of 5600 ± 170 M-1min-1 and 2900 ± 420 M-1min-1 for G208A and G208S, respectively, in 
comparison to the 36,000 M-1min-1 observed for native NFU1.  
 





 Similar to the native and single mutant constructs, all of the double mutant 
constructs were readily chemically reconstituted using ferric chloride, L-cysteine and Tm 
NifS, and yielded the expected charge transfer bands at 420 nm and 330 nm indicative of 
[2Fe-2S] cluster binding (Fig. 11A). Based on iron quantitation, reconstitution yields 
varied from 0.62 cluster/dimer for C210A, 0.86 for C213A, 0.65 for C210S, and 0.57 for 
C213S, which are slightly lower than those typically achieved for the native construct 
[28,108]. Protein oligomerization around the cluster was confirmed by use of AUC, while 
monitoring at 420 nm to assess the cluster-bound form of the protein. Dimeric and 
tetrameric species accounted for the majority of holo samples, with a preference for dimer 
formation for C210A and C210S, and tetramer formation in the C213A and C213S samples 
(data not shown).  
 Analysis of the native protein has demonstrated its ability to receive a [2Fe-2S] 
cluster from holo donor proteins IscU and Isa1, as well as the [2Fe-2S](GS)4 complex 
[27,28,90]; however, similar to the G208C mutant, none of the double mutants were able 
to receive cluster from any physiologically-relevant source (data not shown).  
 Chemically reconstituted NFU1 double mutants were able to transfer the [2Fe-2S] 
cluster to various targets. As such, the cluster on the mutants constructs could be extracted 
in the presence of excess glutathione, as observed for the native protein and G208 single 
mutants [28,108]. Cluster transfer was monitored at 420 nm using UV-vis over the course 
of 1 h, and the corresponding decrease in absorbance was used to calculate kobs. The 




using linear regression to obtain a second-order rate constant (Figure 11, Table 13; Figure 
S3).  Both C210 double mutants yielded smaller rate constants, relative to the native NFU1, 
with transfer occurring at 60 ± 3 M-1min-1 for C210A and 81 ± 8 M-1min-1 for C210S.The 
rate constant for the C213A construct is comparable to that of native protein, at 133 ± 5 M-
1min-1. Only C213S showed a significantly larger rate constant than native, at 250 ± 10 M-
1min-1.  
Similar to the native and single mutant constructs, the holo double mutant constructs 
were each capable of delivering an iron-sulfur cluster to apo protein targets, although 
with perturbed rate constants. Cluster transfer reactions were monitored over the course 
of 1 h by CD, as outlined earlier. Most holo double mutants transferred cluster to Fdx1 
and Fdx2 targets more rapidly than the native protein, with a dramatic increase in rate 
observed for the C210A and C213A constructs (Table 13). All transfers to Grx3 were 
demonstrably slower than observed for native, with the smallest second-order rate 
constant observed for the C210S construct. The most varied response among the double 
mutants was observed in transfer to Grx2. None of the C210 double mutants were able to 
transfer cluster to Grx2, whereas the C213A transfer yielded a higher second-order rate 
constant, and the C213S transfer yielded a slightly lower rate constant (Table 13). 
Representative transfers are shown in Fig 12. 
4.4 Discussion 
 Mutations of the human Fe/S protein NFU1 have been implicated in Multiple 
Mitochondrial Dysfunctions Syndrome 1 (MMDS1), with the majority of patients showing 




reported from our laboratory have examined the G208C mutation and suggest the disease 
condition to be a result of increased dimer formation in the apo state, which impairs cluster 
delivery to NFU1 from physiologically relevant sources and prevents downstream cluster 
transfer to key apo targets [108]. However, an additional disruptive possibility exists with 
the G208C mutation, in that the presence of an additional cysteine near the Fe/S cluster 
binding motif of CXXC may interfere or perturb the cluster coordination sphere due to the 
presence of a third potential cluster binding ligand. For this reason, we have sought to 
examine the influence of this extra cysteine on protein structure-function relationship and 
cluster stability via a series of residue substitutions in the cluster binding pocket (Table 1). 
Derivatives were made that 1) examined the role of position 208 (G208A and G208S), and 
2) analyzed the possibility of altered cluster coordination motifs on NFU1 through a series 
of double mutant constructs that created either CXCXXA/S or CXA/SXXC motifs by 
substituting residues at positions 210 or 213 (Table 1). Alanine and serine are sterically 
similar to cysteine, but differ in polarity and ability to bind a Fe/S cluster. Replacement of 
a cysteine residue at position 210 or 213, by either an alanine or serine to create double 
mutants, has allowed us to delineate structural and functional effects based on position and 
residue.   
 To begin to examine the cluster binding motif and any alterations introduced by 
substitutions, we began with an analysis of apo protein stability characteristics. Purified 
protein constructs were first examined thermodynamically in terms of secondary and 
tertiary structure in the apo state using VTCD and DSC. No significant differences were 




secondary structure via VTCD for both the single and double mutant constructs (Tables 2 
and 7), despite different contributions to secondary structural elements (Tables 3 and 8). 
Therefore, increasing the amount of random coil has not perturbed the overall level of 
protein stability for these NFU1 constructs such that there is no observable difference in 
melting temperature. Similar patterns were observed with DSC analysis, since there were 
no major differences in melting temperature or van’t Hoff enthalpy relative to the native 
construct (Tables 4, 5, 9, and 10). Although no thermodynamic differences were observed, 
significant changes were observed in the shape of the DSC traces.  
Our previous characterization of the native human NFU1 demonstrated two peaks 
in the melting trace, which were attributed to the molten globular C-terminal domain 
melting at the lower temperature and the structured N-terminal domain melting at the 
higher temperature [49]. However, characterization of the G208C apo state showed three 
melting peaks, which we attributed to the C-terminal domain unfolding followed by dimer 
dissociation and finally the N-terminal domain unfolding, based on the high percentage of 
dimer observed in AUC [92,93,108]. Surprisingly, none of the other 208 single mutants or 
the double mutant constructs demonstrated a third peak in the melting trace, which caused 
them to more resemble the native form (Figures 2 and 5). For the 208 single mutants, this 
likely correlates with the significantly lower percentages of dimer observed in AUC (Table 
6, Figure 3). However for the double mutants, because the dimer form is still present, dimer 
unfolding most likely occurs in a concerted manner with the C-terminal domain, which has 
been observed for the native form of the protein [92,93,108]. The minor differences 




oligomer, which could shift the Tm either slightly higher or lower depending on the inherent 
stability of the complex.  
Differences observed in the oligomeric states of the apo protein highlight the 
importance of the residue at position 208. Replacement of glycine with either alanine or 
serine, both with increased α-helical propensity [95], severely shifted the oligomeric state 
towards monomer (Table 6, Figure 3); whereas the native glycine and mutant cysteine, 
both with a decreased α-helical propensity [95], promoted dimer formation [108]. This 
trend extends to the double mutant variants, and provides a ready explanation for the 
observed changes in global structure. Having both the G208C mutation and the mutation 
at position 210 maintained the oligomeric trends of the single mutant form (Table 11, 
Figure 6), confirming the importance of the amino acid at position in 208 in dictating 
oligomerization trends. Furthermore, in addition to maintaining the dimer state, protein 
derivatives of G208C, with substitutions at 213, promote tetramer formation to almost a 
quarter or a half of the overall composition (Table 11), again highlighting the importance 
of residue 208 and showcases the functional role of the cluster binding motif in regulating 
structure-function relationships of human NFU1. Minor mutations to this motif promote 
global change in protein structure that both alter protein oligomerization, and influence 
downstream cluster binding and transfer capabilities. 
The crucial nature of this structure-function relationship is observed in the ability 
of these NFU1 mutant variants to receive a Fe/S cluster from physiologically relevant 
sources. In the case of the G208C single mutant, the high prevalence of dimer prevented 




IscU, even in the presence of chaperones [108]. In accordance with this observation for 
G208C NFU1, the primarily monomeric G208A and G208S derivatives (Table 6) were 
both able to receive cluster from donor proteins (Table 12), and G208A was even able to 
take up cluster from the [2Fe-2S](GS)4 complex (Fig 13). Similarly, all of the double 
mutants were unable to receive cluster from the same sources (Table 13), due to their high 
percentages of dimer and other higher-order oligomeric states (Fig 13). The inability of the 
double mutants to receive cluster was not due to dysfunctional Fe/S cluster binding motifs, 
as those same motifs have already been observed in nature [120-123] and the mutants were 
all able to undergo chemical reconstitution and cluster transfer to [2Fe-2S] cluster proteins 
(Table 13).  
All of the mutant constructs made and tested herein were able to undergo 
reconstitution and transfer their Fe/S cluster to downstream targets. AUC of the holo 
proteins confirmed that the cluster-bound forms maintain oligomeric states similar to those 
observed in the native form, indicating a binding scenario similar to the native. However, 
just as the mutations altered the oligomeric states of the apo form, the cluster transfer 
activities of the holo form were also perturbed. In terms of the single mutant constructs, 
the second-order rate constants for transfer to either the ferredoxins or free GSH were 
drastically increased, while the rate constants for Grx3 were found to decrease (Table 12). 
This contrasts with the transfer reactions observed for G208C, which showed decreased 
rate constants for transfer to the ferredoxins, and unaffected transfer to free GSH [108]. 
Since the rates were so drastically different with the single mutants, which were designed 




change that perturbs the oligomeric state simultaneously dictates the effects observed on 
transfer reactivity; inasmuch as the mutation at position 208 alters the structural 
characteristics that in turn promotes transfer to ferredoxins with increased cluster 
reactivity. However, in the case of Grx3, the transfer reaction is slowed, most likely 
reflecting a structural change that either blocks a protein-protein interaction or perturbs the 
recognition surface in a unique way given the dimeric nature of Grx3, in contrast to 
monomeric ferredoxins.  
Likewise, double mutant derivatives demonstrated the same overall trends with 
faster transfer to the ferredoxins and slower transfer to Grx3 (Table 13). Even with their 
altered cluster coordination spheres, a similar phenomena may be occurring in terms of the 
oligomeric states. The new coordination scheme could make the holo form of human NFU1 
less stable and make cluster transfer to ferredoxin easier. Similarly, the new ligation sphere 
may alter protein structure and interfere with cluster transfer to Grx3 in the same manner 
as for the single mutants. Interestingly, the S variants of the double mutants, either at 
position 210 or 213, demonstrated transfer rates to the ferredoxins most like the native 
human NFU1 (Table 13). In these constructs, one possible explanation is that the serine 
can function as a cluster ligand to maintain the original spacing of the archetypical CXXC 
motif, as the supported by the native-like kinetic transfer rates [65,118]; however, UV and 
CD of the holo double mutant constructs yield similar spectra, which contrasts with prior 
optical characterization of cysteine to serine rubredoxin and ferredoxin mutants that 
demonstrate similar, yet less intense UV spectra and shifted peaks in CD spectra [118,124]. 




less than the equivalent alanine substitution promoting similar cluster transfer properties to 
the native protein.   
For all of the mutant variants examined, the second-order rate constants for transfer 
to Grx2 did not seem to follow a clear trend. For the single mutants, the rate constant 
increased for G208A and decreased for G208S (Table 12). In terms of the double mutants, 
the rate constant for G208C C213A increased, but was observed to decrease for G208C 
C213S, while the 210 variants showed no transfer reaction at all (Table 13). These results 
reflect a very nuanced view of protein-protein interaction that is sensitive to minor 
perturbations in protein structure or oligomeric state, which is unique for each of the 
different constructs.   
Together the rate data, in combination with the apo protein stability data and 
information on oligomeric states, provide insight into structure-function relationships for 
human NFU1. Our mutational analysis suggests that the G208C mutation does not 
contribute to cluster binding, but instead alters the overall structure-function relationships 
of the protein through changes in oligomerization state, and it is these more global 
structural changes, rather than any direct change in cluster coordination, that result in 





4.5 Figures and Tables 
 
Figure 4-1 A representative VTCD trace for the melting of 10 μM G208A  
in 40 mM phosphate, pH 7.4. Data were fit to equation 1 to obtain Tm and ΔHV, which are 
shown in Table 2. CD units of ellipticity (mdeg) were used directly without conversion to 
molar ellipticity because the van’t Hoff enthalpies are independent of such a factor [49]. 
 
 
Figure 4-2 Differential scanning calorimetry profiles  
for (A) G208A NFU1 and (B) G208S human NFU1.Both of the proteins were in 0.2 mM 
solutions in 50 mM HEPES, 100 mM NaCl, and pH 7.4. The data were fit using Origin 7.0 
to obtain Tm, ΔHcal, and ΔHV values, all of which are listed in Tables 4 and 5.  
























Figure 4-3 Analytical ultracentrifugation profiles for G208A and G208S NFU1.  
(A) Apo G208A was sedimented in the absence of TCEP (black) and in the presence of 1 
mM TCEP (red). Sedimentation was monitored at 280 nm. (B) Apo G208S was also 
sedimented in the absence of TCEP (black) and in the presence of 1 mM TCEP (red) and 
monitored at 280 nm. The AUC results were fit to the Lamm equation [79] using a 
continuous distribution model to obtain the peaks and molecular weights shown above. The 






Figure 4-4 A representative VTCD trace  
for the melting of 10 μM G208C C213A NFU1 in 40 mM phosphate, pH 7.4. Data were 
fit to equation 1 to obtain Tm and ΔHV, which are shown in Table 2. CD units of ellipticity 
(mdeg) were used directly without conversion to molar ellipticity because the van’t Hoff 





Figure 4-5 Differential scanning calorimetry profiles for the NFU1 double mutants. 
(A) G208C C210A NFU1, (B) G208C C210S NFU1, (C) G208C C213A NFU1, and (D) 
G208C C213S NFU1. All of the proteins were 0.2 mM and in 50 mM HEPES, 100 mM 
NaCl, and pH 7.4. The data were fit using Origin 7.0 to obtain Tm, ΔHcal, and ΔHV values, 






Figure 4-6 Analytical ultracentrifugation profiles for the NFU1 double mutants.  
(A) Apo G208C C210A was sedimented in the absence of TCEP (black) and in the 
presence of 1 mM TCEP (red). Sedimentation was monitored at 280 nm. (B) Apo G208C 
and C213A, (C) Apo G208C and C210S, and (D) Apo G208C and C213S were also 
sedimented in the absence of TCEP (black) and in the presence of 1 mM TCEP (red) and 
monitored at 280 nm. The AUC results were fit to the Lamm equation [79,111] using a 
continuous distribution model to obtain the peaks and molecular weights shown above. The 





Figure 4-7 Kinetics of [2Fe-2S] cluster transfer from the [2Fe-2S](GS)4 complex to apo 
G208A NFU1.  
(A) Time course for cluster transfer monitored by CD in 50 mM HEPES, 100 mM NaCl, 
pH 7.5. Spectra were recorded every 2 min after the addition of the [2Fe-2S](GS)4 complex 
and converted to percent cluster transfer (B) and fit using DynaFit [89] to yield the apparent 






Figure 4-8 Kinetics of [2Fe-2S] cluster transfer from holo reconstituted Fe/S cluster donors 
IscU and Isa1 to apo G208S NFU1. 
 (A) Time course for cluster transfer from Isa1 to G208S NFU1 monitored by CD in 50 
mM HEPES, 100 mM NaCl, pH 7.5. Spectra were recorded every 2 min following the 
addition of holo Isa1, and converted to percent cluster transfer (B) and fit using DynaFit 
[89] to yield an apparent second-order rate constant 3200 ± 850 M-1 min-1 based on the 
concentration of the [2Fe-2S] cluster. (C) Time course for cluster transfer from holo IscU 
to apo G208A NFU1 recorded by CD under the same conditions as for Isa1. (D) Due to the 
rapid cluster transfer, the reaction was run again at intervals of 10 sec, and the CD signal 
was converted to the percentage of cluster transferred with time to yield an apparent 





Figure 4-9 GSH extraction of the [2Fe-2S] cluster  
from 10 μM reconstituted holo G208A human NFU1 to form the [2Fe-2S](GS)4 complex. 
The change in absorbance at 420 nm was monitored over the course of one hour and data 
were fit to an exponential to obtain the kobs. (A) Shows a representative UV trace of the 
reconstituted G208A in the presence of 200 μM GSH and the corresponding decrease in 
absorbance at 420 nm over the course of 1 h. (B) The change in absorbance at 420 nm was 
plotted against time for each of the different concentrations of GSH and fit to an 
exponential to obtain the kobs for each concentration. Sample traces are shown for 1 mM 
GSH (black) and no GSH (red). (C) kobs data was plotted against GSH concentration to 
determine an overall second-order rate constant of 520 ± 80 M-1min-1, an apparent 
dissociation constant KD of 0.426 M and a first order rate constant k1 for formation of the 
[2Fe-2S](GS)4 complex of 1.7 x 10-4 min-1, similar to values obtained with other 





Figure 4-10 Kinetics of a representative [2Fe-2S] cluster transfer from holo reconstituted 
G208A NFU1 to apo targets.  
(A) Time course for cluster transfer from G208A NFU1 to ferredoxin 1 (Fdx1) monitored 
by CD in 50 mM HEPES, 100 mM NaCl, pH 7.5. Spectra were recorded every 2 min after 
the addition of holo G208A, and converted to percent cluster transfer. Due to the rapid 
cluster transfer, the reaction was monitored again at intervals of 10 sec at 445 nm  and  
percent cluster transfer data (B) was extracted and  fit using DynaFit [89] to yield an 
apparent second-order rate constant 12000 ± 2800 M-1min-1 based on the concentration of 
the [2Fe-2S] cluster. (C) Time course for cluster transfer from holo G208A to apo 
glutaredoxin 3 (Grx3) recorded by CD under the same conditions as for Fdx1. (D) CD 
signal was converted to the percentage of cluster transferred with time to yield an apparent 







Figure 4-11 GSH extraction of the [2Fe-2S] cluster  
from 10 μM reconstituted holo G208C C213A human NFU1 to form the [2Fe-2S](GS)4 
complex. The change in absorbance at 420 nm was monitored over the course of an hour 
and data were fit to an exponential decay to obtain kobs. (A) Shows a representative UV 
trace for reconstituted G208C C213A NFU1 in the presence of 500 μM GSH and the 
corresponding decrease in absorbance at 420 nm over the course of 1 h. (B) The change in 
absorbance at 420 nm was plotted against time for each of the different concentrations of 
GSH and fit to an exponential to obtain kobs for each concentration. Sample traces are 
shown for 1 mM GSH (black) and no GSH (red). (C) kobs data was plot against the 
concentration of GSH and fit to a linear equation to yield an overall second-order rate 






Figure 4-12 Kinetics of a representative [2Fe-2S] cluster transfer from holo reconstituted 
human G208C C213A NFU1 to apo human ferredoxin and glutaredoxin.  
(A) Time course for cluster transfer to ferredoxin 1 (Fdx1) monitored by CD in 50 mM 
HEPES, 100 mM NaCl, pH 7.5. Spectra were recorded every 2 min following the addition 
of holo NFU1, and converted to percent cluster transfer (B) and fit using DnyaFit [89] to 
yield an apparent second-order rate constant 19000 ± 2900 M-1min-1 based on the 
concentration of the [2Fe-2S] cluster. (C) Time course for cluster transfer from holo human 
NFU1 to apo human glutaredoxin 2 (Grx2) recorded by CD under the same conditions as 
for Fdx1. (D) The CD signal was again converted to the percentage of cluster transferred 





Figure 4-13 (A) A model for [2Fe-2S] cluster uptake by monomeric NFU1, 
 such as in the case of native and G208A, from the [2Fe-2S](GS)4 cluster complex to form 
an intermediate [2Fe-2S] species with two exogenous GSH ligands. NFU1 is represented 
by the N and C terminal domains. A second monomeric NFU1 displaces the GSH 
molecules to form [2Fe-2S] dimeric NFU1. (B) A model for [2Fe-2S] cluster uptake by 
monomeric NFU1 from a [2Fe-2S] cluster scaffold, such as IscU, as in the case of native 
and G208S. Holo IscU interacts with monomeric NFU1 to form a transient heterodimeric 
complex. A second NFU1 monomeric displaces the now apo IscU to form the holo NFU1 
dimer.  In a case where NFU1 is a pre-formed dimer (C), such as in the G208C mutant and 
the double mutants, the dimeric NFU1 is unable to form the transient complex with holo 













Construct Sequence Construct Sequence 
Native QGSCTSCP G208C C210A QCSATSCP 
G208C QCSCTSCP G208C C210S QCSSTSCP 
G208A QASCTSCP G208C C213A QCSCTSAP 
G208S QSSCTSCP G208C C213S QCSCTSSP 
Table 4-1The series of point mutations designed in the native NFU1 construct,  
relative to the native construct and the physiologically-relevant disease-causing G208C 
mutation. The glycine residue at position 208 was replaced with either alanine or serine, to 
monitor substitution effects related to size or alterations in Fe/S cluster binding. Double 
mutant constructs were created by maintaining the G208C mutation and replacing one of 
the cluster-binding cysteine residues at 210 or 213 with either alanine or serine to 
investigate differences in cluster-binding behavior as a result of change to the typical 
CXXC motif.  
 
 Tm (°C) ∆Hv (kcal/mol) 
Native 65 ± 0.5 -26 ± 2 
G208A 66 ± 2 -25 ± 6 
G208C 64 ± 2 -31 ± 2 
G208S 65 ± 0.5 -32 ± 2 
Table 4-2 Single mutant variable temperature circular dichroism results.  
Proteins at 10 μM were subjected to melting from 20 to 95 °C at 0.4 °C per min. Data were 
fit to a one-state melting process using equation 1 [49,108]. 
 α-helix β-sheet Random Coil 
Native 47 % 21 % 33 % 
G208A 21 % 22 % 58 % 
G208C 37 % 17 % 46 % 
G208S 25 % 20 % 55 % 
Table 4-3 Percentages of single mutant secondary structural elements  
measured by circular dichroism and analyzed using the analysis program CDSSTR [73] on 






 Tm1 (°C) Tm2 (°C) Tm3 (°C) 
Native 59 ± 1 -- 73 ± 1 
G208A 52 ± 3 -- 74 ± 1 
G208C 49 ± 6 64 ± 2 74 ± 4 
G208S 61 ± 3 -- 75 ± 1 
Table 4-4 Single mutant melting temperatures determined from fits to DSC data. 
 The DSC profiles used for fitting are shown in Figure 2 [108]. 
 
 ∆Hcal1 ∆Hv1 ∆Hcal2 ∆Hv2 ∆Hcal3 ∆Hv3 
Native 73 ± 2 39 ± 1 -- -- 122 ± 2 77 ± 1 
G208A 25 ± 4 34 ± 1 -- -- 35 ±19 43 ± 5 
G208C 5 ± 1 33 ± 4 39 ± 2 50 ± 2 23 ± 4 74 ± 16 
G208S 39 ± 2 32 ± 1 -- -- 34 ± 9 76 ± 7 
Table 4-5 Single mutant enthalpies of melting determined by DSC  





Monomer  With TCEP  Dimer  With TCEP  Tetramer  With TCEP  
Native  45 %  44 %  52 %  44 %  0 % 0 % 
G208A  70 %  76 %  22 %  14 %  2 %  1 %  
G208C  29 %  30 %  58 % 60 %  6 % 1.5 %  
G208S  90 %  93 %  8 %  7 %  0%  0%  
Table 4-6 Analytical ultracentrifugation results of the single mutants 
 in the presence and absence of TCEP. The obtained molecular weights were classified 





 Tm (°C) ∆Hv (kcal/mol) 
Native 65.3 ± 0.5 -26 ± 2 
G208C C210A 70 ± 3 -26 ± 1 
G208C C210S 69 ± 0.5 -38 ± 10 
G208C C213A 68 ± 1 -30 ± 5 
G208C C213S 67 ± 0.5 -33 ± 5 
Table 4-7 Double mutant variable temperature circular dichroism results.  
Proteins at 10 μM were subjected to melting from 20 to 95 °C at 0.4 °C per min. Data were 




 α-helix β-sheet Random Coil 
Native 0.47 0.21 0.33 
G208C C210A 0.24 0.19 0.57 
G208C C210S 0.19 0.21 0.61 
G208C C213A 0.44 0.21 0.36 
G208C C213S 0.42 0.18 0.4 
Table 4-8 Percentages of double mutant secondary structural elements  
measured by circular dichroism and analyzed using the analysis program CDSSTR [73] on 
the online Dichroweb server  [75,76,108]. 
 
 Tm1 (˚C) Tm2 (˚C) 
Native 59 ± 1 73 ± 1 
G208C C210A 54 ± 4 79 ± 1 
G208C C210S 57 ± 4 74 ± 2 
G208C C213A 48 ± 1 66 ± 2 
G208C C213S 63 ± 1 72 ± 2 
Table 4-9 Double mutant melting temperatures determined from fits to DSC data. 





 ∆Hcal1 ∆Hv1 ∆Hcal2 ∆Hv2 
Native 73 ± 2 39 ± 1 122 ± 2 77 ± 1 
G208C C210A 87 ± 8 20 ± 1 119 ± 9 35 ± 5 
G208C C210S 37 ± 2 30 ± 4 53 ± 3 68 ± 2 
G208C C213A 115 ± 4 45 ± 6 91 ± 4 46 ± 1 
G208C C213S 17 ± 7 32 ± 1 46 ± 3 50 ± 6 
Table 4-10 Double mutant enthalpies of melting determined by DSC  
All values in kcal/mol. The DSC profiles used for data fitting are shown in Figure 5 
[49,108].  
 
 Monomer With TCEP Dimer With TCEP Higher-Order With TCEP 
Native 45% 44% 52% 44% -- -- 
C210A 40% 44% 54% 46% 1% 5.1% 
C210S 33% 36% 58% 58% 1% 4% 
C213A 35% 31% 46% 41% 16% 21% 
C213S 21% 25% 23% 21% 47% 46% 
Table 4-11 Analytical ultracentrifugation results fot the double mutant NFU1 proteins 
in the presence and absence of TCEP. The obtained molecular weights were classified 
according to the most likely corresponding oligomeric state. The designation of higher-










 Native G208C G208A G208S 




2560 ± 340 12000 ± 2800 19000 ± 1700 




1180 ± 220 13000 ± 1500 20000 ± 510 
Human NFU1 to 
human Grx2 
3700 ± 77 22400 ± 5000 6300 ± 380 1500 ± 97 




14500 ± 3500 5600 ± 170 2900 ± 420 
Human IscU to 
human NFU1 
4750 ± 8 No transfer No transfer 2300 ± 90 




No transfer No transfer 3200 ± 850 




No transfer 3500 ± 500 No transfer 
Human NFU1 to 
GSH 
130 ± 22 142 ± 24 520 ± 80 210 ± 70 
Table 4-12 Apparent second-order rate constants determined using CD for [2Fe-2S] cluster 
transfer to and from native and single mutant NFU1.  
Native and G208C transfer rates were previously determined [27,28,90]. All rate constant 

























19000 ± 2900 5100 ± 800 
23000 ± 
6600 
7500 ± 2000 





7700 ± 1100 4100 ± 540 
12000 ± 
3700 
3100 ± 420 




8800 ± 3800 2500 ± 30 No transfer No transfer 











7400 ± 1500 




No transfer No transfer No transfer No transfer 










No transfer No transfer No transfer No transfer 




133 ± 5 250 ± 10 60 ± 3 81 ± 8 
Table 4-13 Apparent second-order rate constants determined using CD for [2Fe-2S] cluster 
transfer to and from native and double mutant NFU1. 












Appendix A : Chapter 2 Supplementary Data 
 
 
Figure A-1 Standard curve for iron quantitation. 
 Absorbance at 535 nm was measured by UV-Vis spectroscopy for 1 - 200 µM FeCl3 
standard solutions to generate the calibration curve, which was then utilized to determine 
the iron concentration for the holo proteins.  
 
 




























Figure A-2 Limited proteolysis of native human NFU1 (A) and G208C NFU1 (B).  
Both proteins (0.5 mg/mL) were incubated with the specified protease (none, trypsin, or 
chymotrypsin) in a 1:100 ratio of protease:protein in 50 mM HEPES, 100 mM NaCl, 5 mM 
CaCl2, pH 7.5. After 0, 2, 10 min at room temperature, the reaction was quenched by the 
addition of reducing SDS sample buffer, supplemented with 2 mM PMSF and 10 mM 
EDTA [125]. Samples were boiled for 5 minutes at 95 °C and separated on a 15% SDS-







Figure A-3 Analytical ultracentrifugation profiles for holo G208C NFU1. 
 (A) Sedimentation was monitored at 280 nm, and the AUC results were fit to the Lamm 
equation [79,111] using a continuous distribution model to obtain the peaks and molecular 
weights shown above. The first peak at 22.5 kDa accounts for 25% of the sample, the 
second peak at 44.4 kDa accounts for 50%, and the third peak at 85.3 kDa accounts for 7%. 
(B) Sedimentation of holo G208C was monitored at 420 nm and fit the Lamm as equation 
as for the 280 nm trace. The first peak at 42.6 kDa accounts for 65.6% of the sample, and 
the second peak at 90.a kDa accounts for 16.6%.  
 
 




Cluster transfer from holo human IscU (30 μM) to (A) apo human NFU1 (30 μM) or (B) 
apo human G208C NFU1 (30 μM). Both transfer reactions were carried out in the presence 
of 22 μM HspA9, 22 μM Hsc20, 40 mM MgCl2 and 2 mM ATP and monitored by UV-vis 
CD spectroscopy under anaerobic conditions in semi-micro 1 cm cuvette at room 
temperature. UV-vis CD spectra were recorded every 2 min for 60 min following addition 
of MgCl2 and ATP, and then the cluster-bound holo human IscU.  






Figure A-5 ESI-MS spectrum showing the cluster complex  
at 1427.3 and reaction intermediates at m/z of 1413.3 and 1435.3 representing sodium 
adducts of the [2Fe-2S](GS)4 complex [126,127]. Holo G208C NFU1 at 100 μM was 
incubated anaerobically with 10 mM GSH, pH 8.6 for 2 h. The resulting reaction mixture 





























Figure A-6 DTT Incubation 







Figure A-7 Holo IscU to Fdx2 with chaperones.  
Cluster transfer from holo human IscU (30 μM) to apo human Fdx2 (30 μM) in the presence 
of 22 μM HspA9, 22 μM Hsc20, 40 mM MgCl2 and 2 mM ATP monitored by UV-vis CD 
spectroscopy under anaerobic conditions in semi-micro 1 cm cuvette at room temperature. 
UV-vis CD spectra were recorded every 2 min for 60 min following addition MgCl2 and 
ATP, and then the cluster bound form holo human IscU. The kinetics of appearance of the 
holo ferredoxin 2 CD signal (A) was monitored. The change in extinction values are based 
on the initial [2Fe-2S]2+ cluster concentration. The apparent second order rate constants 








 Rate Constant in the 
Absence of Chaperones 
(M-1min-1) 
Rate Constant in the 
Presence of Chaperones 
(M-1min-1) 
Human IscU to human 
Fdx2  
2400 ± 1400    [27] 2400 ± 970 
Table A-1 Apparent second-order rate constants 
 determined using CD for [2Fe-2S] cluster transfer from holo human IscU to apo human 
ferredoxin 2 in the absence and presence of the human co-chaperone system and MgATP. 
The transfer rate without the chaperone system was previously determined using the same 




Figure A-8 Holo VTCD traces  
of native NFU1 (left) and G208C NFU1 (right). Both traces were fit to a one-state model 
using equation 1.  







































































Appendix B : Chapter 3 Supplementary Data 
 
 
Figure B-1: VTCD trace for the melting of 10 μM (A) G189A and (B) G189K NFU1  
in 40 mM phosphate, pH 7.4. Data were fit to equation 1 to obtain Tm and ΔHV values, which are 
summarized in Table 1. CD units of ellipticity (mdeg) were used directly without conversion to 
molar ellipticity because the van’t Hoff enthalpies are independent of such a factor [49].  
 
 
Figure B-2 Differential scanning calorimetry profiles for (A) 0.2 mM G189A human 
NFU1, (B) 0.15 mM G189K human NFU1  
 
Both of the proteins were in 50 mM HEPES, 100 mM NaCl, and pH 7.4. The data were fit 







Figure B-3 AUC profile for (A) apo G189A NFU1 and (B) apo G189K NFU1 
Apo protein was sedimented in the absence of TCEP (black) and in the presence of 1 mM 
TCEP (red). Sedimentation was monitored at 280 nm. For G189A NFU1, the first peak of 
the black trace at 23.7 kDa accounts for 95% of the sample, and the second peak at 66.3 
kDa accounts for 3%. The first peak of the red trace at 21.0 kDa accounts for 69% of the 
sample, and the second peak at 74.4 kDa accounts for 2%. For G189K, the first peak of the 
black trace at 24.8 kDa accounts for 93% of the sample, and the second peak at 60.6 kDa 
accounts for 5% of the sample. The first peak of the red trace at 24.9 kDa accounts for 89% 
of the sample, and the second peak at 61.7 kDa accounts for 6% of the sample. The AUC 
results were fit to the Lamm equation [79,111] using a continuous distribution model to 






Figure B-4 A [2Fe-2S] cluster transfer from holo reconstituted S. pombe Isa1 to apo G189A 
NFU1 
 
(A) Time course for cluster transfer to G189A NFU1 monitored by CD in 50 mM Hepes 
and 100 mM NaCl (pH 7.5). Spectra were recorded every 2 min after the addition of holo 
Isa1 and were converted to percent cluster transfer (B) to yield an apparent second-order 
rate constant from DynaFit of 1800 ± 100 M−1 min−1 based on the concentration of the [2Fe-










Figure B-5 GSH extraction of the [2Fe-2S] cluster from G189X NFU1 
(A) 10 μM G189R NFU1, (B) 10 μM G189A NFU1, and (C) 10 μM G189K NFU1, to 
form the [2Fe-2S](GS)4 complex. The change in absorbance at 420 nm was monitored over 
the course of one hour and the initial slopes were fit to an linear equation to obtain kobs 
values that were subsequently plotted against GSH concentration to determine an overall 
second-order rate constant of 1800 ± 30 M-1min-1 for (A), 360 ± 70 M-1min-1 for (B), and 
1200 ± 70 M-1min-1 for (C). The data were also fit to an exponential equation to determine 
the apparent Kd and first-order rate constants (Table S2) [26].  
 
 
Figure B-6 A representative [2Fe-2S] cluster transfer reaction monitored using circular 
dichroism spectroscopy.  
(A) Time course of [2Fe-2S] cluster transfer from holo reconstituted human G189R NFU1 
to apo S. cerevisiae glutaredoxin 3 (Grx3) monitored by CD in 50 mM Hepes and 100 mM 
NaCl (pH 7.5). Spectra were recorded every 2 min after the addition of holo G189R NFU1. 
However transfer was too rapid to monitor, so cluster transfer was monitored from 465-








based on the 







G189R – Forward  5’-CCAACTGTGCAGGAAGATCGAGGGGATGTAATCT-3’ 
G189R – Reverse 5’-AGATTACATCCCCTCGATCTTCCTGCACAGTTGG-3’ 
G189A – Forward 5’-AACTGTGCAGGAAGATGCAGGGGATGTAATCTACA-3’ 
G189A – Reverse 5’-TGTAGATTACATCCCCTGCATCTTCCTGCACAGTT-3’ 
G189K – Forward 5’-AATACGGCCAACTGTGCAGGAAGATAAAGGGGATGTAATCT-3’ 
G189K – Reverse  5’-AGATTACATCCCCTTTATCTTCCTGCACAGTTGGCCGTATT-3’ 
Table B-1 A list of primers used to conduct site-directed mutagenesis on the human NFU1 
constructs.  
The substituted nucleotides are in bold black and underlined. 
 
Construct K k1 
G189A 0.00009 ± 0.00006 0.18 ± 0.03 
G189K 0.00012 ± 0.00007 0.31 ± 0.05 
G189R 0.00032 ± 0.00018 1.4 ± 0.2 
Table B-2 Apparent dissociation constants K (M) for the pre-reaction complex of holo 
protein and GSH and first-order rate constants k1 (min-1)  
for formation of the [2Fe-2S](GS)4 complex during cluster extraction from holo proteins 











Equation 4 Two-State VTCD Unfolding Model 
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VTCD data were fit to equation 4 for a two-state model indicative of a two-phase transition 
[49], where R is the ideal gas constant in calories per mole, Tm is the melting temperature 
in Kelvin, ΔHV is the van’t Hoff enthalpy, and Cp is the heat capacity. F and U represent 
the mean residue ellipticities (θmr) of the folded and unfolded protein, respectively. It has 
been previously determined that the first observed transition can be assigned to the 
secondary structure transition of the melting C-terminal domain, and the second transition 
is indicative of the melting of the N-terminal domain [49].  The subscripts on Tm, ΔHV, Cp 
and U denote the transition parameters on the separate protein domains, with 1 for the C-







Appendix C : Chapter 4 Supplementary Data 
 
 
Figure C-1 VTCD trace for the melting of 10 μM G208S  
in 40 mM phosphate, pH 7.4. Data were fit to equation 1 to obtain Tm and ΔHV, which are 
summarized in Table 2. CD units of ellipticity (mdeg) were used directly without 










Figure C-2 VTCD traces  
for the melting of (A) 10 μM G208C C210A, (B) 10 μM G208C C210S, and (C) 10 μM 
G208C C213S in 40 mM phosphate, pH 7.4. Data were fit to equation 1 to obtain Tm and 
ΔHV, which are summarized in Table 2. CD units of ellipticity (mdeg) were used directly 
without conversion to molar ellipticity because the van’t Hoff enthalpies are independent 




Figure C-3 GSH extraction of the [2Fe-2S] cluster  
from (A) 10 μM G208C C210A, (B) 10 μM G208C C210S, and (C) 10 μM G208C C213S, 
to form the [2Fe-2S](GS)4 complex. The change in absorbance at 420 nm was monitored 
over the course of one hour and data were fit to an exponential to obtain kobs values that 
were subsequently plotted against GSH concentration to determine an overall second-order 










G208A - Forward 5’-CAGCTGAAACTCCAGGCTTCTTGTACCAGCTGC-3’ 
G208A - Reverse 5’-GCAGCTGGTACAAGAAGCCTGGAGTTTCAGCTG-3’ 
G208S - Forward 5’-GTACAGCTGAAACTCCAGTCTTCTTGTACCAGCTGCCC-3’ 
G208S - Reverse 5’-GGGCAGCTGGTACAAGAAGACTGGAGTTTCAGCTGTAC-3’ 
G208C C210A - Forward 5’-CTGAAACTCCAGTGTTCTGCTACCAGCTGCCCTAGTTC-3’ 
G208C C210A - Reverse 5’-GAACTAGGGCAGCTGGTAGCAGAACACTGGAGTTTCAG-3’ 
G208C C210S - Forward 5’-GCTGAAACTCCAGTGTTCTTCTACCAGCTGCC-3’ 
G208C C210S - Reverse 5’-GGCAGCTGGTAGAAGAACACTGGAGTTTCAGC-3’ 
G208C C213A - Forward 5’-CCAGTGTTCTTGTACCAGCGCCCCTAGTTCAATCATTACT-3’  
G208C C213A - Reverse 5’-AGTAATGATTGAACTAGGGGCGCTGGTACAAGAACACTGG-3’  
G208C C213S - Forward 5’-CAGTGTTCTTGTACCAGCTCCCCTAGTTCAATCAT-3’ 
G208C C213S - Reverse 5’-ATGATTGAACTAGGGGAGCTGGTACAAGAACACTG-3’ 
Table C-1 A list of primers used to conduct site-directed mutagenesis on the human NFU1 
constructs.  
The substituted nucleotides are in bold black and underlined, and the Gly208Cys mutation 
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